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The aim of this study was to develop a tissue engineering approach in regenerating the 
annulus fibrosus (AF) as part of an overall strategy to produce a tissue-engineered 
intervertebral disc replacement. The approach was to use bone marrow derived stem cells 
(BMSC) to form cell-sheets and incorporating them onto silk scaffolds to simulate the 
native lamellae of the AF. The in vitro experimental model used to study the efficacy of 
such a system was made up of the tissue engineering AF construct wrapped around a 
silicone disc to form a simulated IVD-like assembly. The AF construct was cultured 
within a custom-designed bioreactor that provided a mechanical stimulation to mimic the 
physiological condition. The results showed that BMSC cell-sheets retain their 
multipotentiality and were a suitable cell source for the simulated AF. The use of the 
bioreactor on the experimental model was shown to further enhance the efficacy in 













1.  INTRODUCTION 1 
Lower Back Pain 2 
 Lower back pain causes discomfort in many individuals. If left untreated and 3 
allowed to deteriorate, discomfort might lead to disability. It is particularly predominant 4 
in 20-50 year olds and get progressively more serious in older people (Biering-Sørensen 5 
1982). It has been reported as the most costly healthcare problem amounting to $50 6 
billion in the United States alone (Frymoyer, & Cats-Baril 1991). Lower back pain is 7 
linked with the degeneration of the inter-vertebral disc (O'Neill et al 2002,Waddell 8 
1996,Schwarzer et al 1995), also known as degenerative disc disease (DDD). Changes in 9 
the matrix composition (Miller et al 1988,Lyons et al 1981) and deterioration of 10 
biomechanical properties (Guiot, & Fessler 2000,Lipson, & Muir 1981), abnormal 11 
mechanical loading (Hutton et al 1998), genetic predisposition, reduced cell activity or 12 
any combination of the three may induce DDD (Lotz, & Chin 2000,Natarajan et al 1994). 13 
 12 
IVD Structure 1 
 An IVD is found in between 2 vertebrae. It is a biologically complex structure 2 
that is separated into 3 tissue types; AF, NP and end-plates (O'Halloran, & Pandit 2007). 3 
 4 
Fig 1a: Schematic drawing of the IVD between 2 vertebrae (left) and saggital section 5 
specimen of the IVD. NP nucleus pulposus, IA inner annulus fibrosus, OA outer annulus 6 
fibrosus (right) 7 
 8 
 The AF is made up of a series of highly oriented concentric layers rich in collagen 9 
surrounding the NP (Roberts et al 1989). The outer AF is made up of mainly collagen 10 
type I and to a much lesser extent, collagen type II. The amount of collagen type I fibres 11 
decrease and collagen type II fibres increase gradually near the NP (Bruehlmann et al 12 
2002). Within these concentric layers, the collagen fibres lie parallel to each other at 13 
approximately 60o angle to the spine axis. The fibres lie in opposite directions between 14 
successive layers (Hickey, & Hukins 1980).  The outer region of the AF attaches to the 15 
posterior longitudinal ligaments and insert into the vertebrae body via Sharpey’s fibres. 16 
The inner AF merges with the NP and the collagen fibres continue into the end-plate 17 
(Cassinelli et al 2001). 18 
 13 
 1 
Fig 1b: Figure showing the alternating arrangements of the fibres  2 
between successive AF lamellae 3 
 4 
 The NP comprises of a more random arrangement of mostly collagen type II 5 
fibres that is dispersed within a proteoglycan-rich gelatinous matrix (Goupille et al 1998). 6 
The NP has a very high affinity for water due to the highly negative sulphated charge. 7 
The hydrostatic pressure exerted by the NP in an outward radial direction keeping the AF 8 
from collapsing inwards and allows it to accommodate compression loads. 9 
 End-plates lie between the vertebral bodies and the IVD. The central zone of the 10 
end-plate is made up of hyaline cartilage found over the perforated bony end-plate and 11 
loosely cemented to the underlying bone by a thin layer of calcium (Moore 2000), while 12 
the peripheral regions near the vertebral rim comprises an osseous component. The 13 
hyaline cartilage allows diffusion of molecules in and out of the disc while the osseous 14 
region is relatively impermeable. The end-plates is critical for the nutrition of the IVD as 15 
diffusion occurs through the central permeable region of the hyaline cartilage via vascular 16 
 14 
buds that provide the bridge between the bone marrow of the vertebral body and the end-1 
plate (O'Halloran, & Pandit 2007). 2 
Together, these structures transmit weight and absorb compressive forces between 3 
adjacent vertebra and contribute significantly to the flexibility and stability needed to 4 
absorb mechanical loading.  5 
In the normal IVD, chondrocyte-like cells synthesize collagen type II, 6 
proteoglycans and other proteins that form the matrix of the NP and the end-plates. 7 
Fibroblast-like cells secrete collagen type I and type II to form the AF. The matrix 8 
components are continually degraded by enzymes like MMPs (Goupille et al 1998), and 9 
are replaced by newly-synthesized matrix. Growth factors such as bFGF, TGF 10 
(Thompson et al 1991) and IGF (Osada et al 1996) also stimulate the chondrocyte-like 11 
and fibroblast-like cells to secrete more matrix. These growth factors are bound by CLIP 12 
and are released when the matrix is degraded (Seki et al 2005) to promote more matrix 13 
formation. TIMPs are also present to suppress MMP activation (Kang et al 1997). 14 
 15 
 16 
Fig 1c: Histological staining of a healthy AF. Blue staining: Alcian Blue; Orange 17 
staining: Safranin-O. Image taken from Leung et al. 2009 18 
 15 
Pathophysiology of Intervertebral Disc Degeneration 1 
 Disc degeneration will occur when the matrix is not normal. This can occur when 2 
the matrix components synthesized are abnormal or if the balances between catabolic and 3 
anabolic factors shift in favour of degredation. When injury occurs to the IVD, 4 
macrophages enter the disc as a response. The machophages produce cytokines such as 5 
IL-1, IFN and TNF-α, which inhibits the synthesis of matrix proteins and increases the 6 
production of MMPs (Kobayashi et al 2005). Macrophages also secrete superoxide (O2-), 7 
which can degrade hyaluronic acid and proteoglycans, causing them to deaggregate, and 8 
can inhibit chondrocyte proliferation and synthesis. TNF-α and IL-1 also stimulates 9 
inducible nitric oxide synthetase to produce nitric oxide (Kang et al 1997) which has a 10 
variety of mechanisms that degrade the matrix. These are the main molecular pathways 11 
that are upregulated when IVD degeneration occurs. A number of factors have been 12 
postulated to be the cause of IVD degeneration 13 
 Aging of the IVD would results in the senescence of the cells causing them to lose 14 
the ability to proliferate  and therefore result in a loss of cell numbers as the disc is unable 15 
to replace those lost to necrosis or apoptosis (Gruber et al 2007).  Cells that have 16 
undergone senescence also are unable to keep up the rate of proteoglycan synthesis 17 
(Johnstone, & Bayliss 1995). The disc has a reduced ability to retain water, absorb 18 
pressure and becomes more fibrous (Haefeli et al 2006) due to the collagen content 19 
increasing and changing from type II to type I (Buckwalter 1995). This causes the NP to 20 
progressively become more solid, dry and granular (Haefeli et al 2006) and cracks will 21 
appear in the fibrous NP. The lamellae in the AF will thicken causing cracks and fissures 22 
to develop within it (Buckwalter 1995). 23 
 16 
 Nutrition would be another contributing factor to IVD degeneration, as the disc is 1 
the largest avascular tissue in they body. The nearest blood supply is found within the 2 
cartilage end-plates of the vertebral body, which would be 7-8mm from the centre of the 3 
disc (Urban et al 2004). The blood supply within the end-plates consists of a continuous 4 
capillary bed that is densest in the region of the NP and reduces significantly as it goes 5 
from the inner AF to the outer AF (Crock, & Goldwasser 1984). While the AF of an 6 
infant was supplied by blood vessels penetrating it, but these disappear by late childhood 7 
leaving only a few small capillaries (Hassler 1969). Calcification of the cartilaginous 8 
end-plates directly affects the ability of nutrients like glucose and oxygen to be 9 
transported from the blood to the cells of the IVD (Roberts et al 1996), and also the 10 
removal of wastes from the IVD. The state of low oxygen levels and lowered pH due to 11 
lactic acid build up will have adverse effects on the rate of matrix synthesis by the IVD 12 
cells (Ishihara, & Urban 1999). It has also been shown that low pH levels do not affect 13 
the ability of MMPs to be produced by the IVD cells (Razaq et al 2003), therefore a loss 14 
of nutrient transport would cause a very rapid breakdown of the IVD. 15 
 Mechanical forces like excessive torsion and compression also have deleterious 16 
effect on the IVD. Torsion occurring within the spine generates tension in the collagen 17 
fibres on one side of the annulus while the collagen fibres on the opposite side are slack 18 
(Krismer et al 1996). AF tears occur when the fibres are damaged. The tears start from 19 
the outer AF and extend inwards to the inner AF. Compressive loads within the 20 
physiological range are the stimulus for matrix turnover (Handa et al 1997). However, 21 
excessive compressive forces can lead to matrix degeneration in the IVD by the 22 
 17 
downregulation genes for all anabolic proteins and the upregulation of catabolic genes 1 
(Neidlinger-Wilke et al 2006). 2 
 18 
Lane Grading System 1 
 There are many different systems of grading IVD degeneration that can be found. 2 
A Medline search found 42 such grading systems that describe cervical, lumbar disc or 3 
facet joint degeneration. Only 4 grading systems from these 42 had the Kappa or ICC 4 
interobserver reliability at > 0.60 (Kettler, & Wilke 2006). The 4 are listed below 5 
1. Thompson et al. : Macroscopy of the Lumbar Disc (Thompson et al 1990) 6 
2. Boos et al. : Histology of the Lumbar Disc (Boos et al 2002) 7 
3. Lane et al. : Plain Radiography of the Lumbar Disc 8 
4. Pfirrmann et al. : Magnetic Resonance Imaging of the Lumbar Disc (Pfirrmann et 9 
al 2001) 10 
The grading system by Thompson et al. and Boos et al. is based on macroscopy and 11 
histology respectively, therefore is not applicable in the clinical diagnostic setting. The 12 
grading system by Lane et al. and Pfirrmann et al. is suitable as radiography and 13 
magnetic resonance imaging are applied. The diagnostic method described by Lane et al. 14 
is more sensitive in detecting end-plate calcification of the IVD. Therefore we’ve 15 
choosen the Lane Grading System to describe different grades of IVD degeneration. 16 
 19 
State of the Art for Lower Back Pain Relief 1 
 In most cases, degeneration of the IVD can be treated successfully non-2 
operatively with medication and physical therapy. However, when all non-operative 3 
treatments are exhausted, an operative treatment will be offered to patients. Currently, 4 
arthrodesis is the standard treatment for degenerative disc disease for patients who failed 5 
all best efforts of conservative care. However, the most notable and overwhelming 6 
problem with arthrodesis surgery is, persistant axial back pain. That is, there is a 7 
persistent disassociation between a radiographically successful fusion and successful 8 
relief of a patient’s pain with return to normal function. Although today’s modern 9 
surgical techniques easily can achieve 95% radiographic fusion rates, clinical success of 10 
pain relief lags behind in the 60% to 80% range (West et al 1991). A recent 2004 11 
retrospective study reported rates of 16.5% at five years and 36.1% at ten years (Ghiselli 12 
et al 2004). Even if spinal fusion has been successful in relieving backache, recognition 13 
of an increased risk of adjacent level disease after fusion is a concern (Gertzbein, & 14 
Hollopeter 2002,Etebar, & Cahill 1999). Despite surgical success with disc arthroplasty, 15 
the problems associated with it have caused surgeons to look for alternatives to fusion. 16 
Another method used to alleviate degenerative disc disease is disc athroplasty. 17 
Total disc replacements (eg. the Charité Artificial Disc, the ProDisc lumbar prosthesis, 18 
Maverick lumbar prosthesis and the FlexiCore lumbar) use a system of metal-metal or 19 
plastic-metal to relief pain by the removal of the diseased disc, restoration of disc height, 20 
and the restoration and maintenance of motion. The disadvantages of this method are that 21 
the site of injury is large.  22 
 20 
There are also nucleus pulposus replacements (eg. The Prosthetic Disc Nucleus 1 
device, Newcleus, Aquarelle, Neudisc). These disc replacements allow the redistribution 2 
of the loads to the remaining native structures; AF and end-plates, and provide a less 3 
invasive surgical procedure. However, there have been reports of implant extrusion 4 
(Shim et al 2003) and end-plate deformities arising from The Prosthetic Disc Nucleus 5 
device. 6 
 None of the treatments listed so far are aimed at dealing with the inherent loss of 7 
function of the native IVD. This has prompted to study of feasible methods of a 8 
biological regenerative approach on treating the degenerating discs. Thus, more emphasis 9 
is being placed on tissue engineering approaches using cell-tissue based constructs that 10 
can function clinically in tissue regeneration and replacement. 11 
 21 
Tissue Engineering  1 
 Tissue engineering is based on the application of concepts in engineering and life 2 
sciences to develop biological substitutes that restore or improve tissue function. It is 3 
founded on 3 main components; cells, signals and scaffolds, which can be used 4 
independently or in any combination.  5 
Scaffold-based tissue engineering uses three-dimensional biodegradable scaffolds 6 
as a short term substitute for the extracellular matrix (ECM), that the seeded cells would 7 
generate their native tissue architecture and replace the role of the scaffold as it degrades 8 
(Langer, & Vacanti 1993). Conventional methods of seeding cells involve culturing of 9 
cells on TCPS until sufficient cells are obtained, followed by enzymatic digestion to 10 
detach the cells from the culture plate and finally seeding the single cell suspension onto 11 
the biodegradable scaffold (Altman et al 2002). This would involve the disruption of 12 
ECM expressed during cell culture and cell-to-cell adhesion proteins produced by the 13 
cells. The disadvantages of this method are that many cells are lost during the process of 14 
seeding onto the scaffolds, as a large portion of the cells do not actually adhere to the 15 
scaffold but seep through the pores of the scaffold (Li et al 2001,Kim et al 1998). 16 
However, those cells that manage to adhere onto the scaffolds have to re-synthesize their 17 
own ECM when they adhere to the new surface. In addition, trypsinization has been 18 
shown to change the morphology and biochemical composition of the cells that leads to a 19 
loss of cellular activity (Fujioka et al 2003).  20 
 22 
Cell-Sheet Tissue Engineering 1 
Currently, there is on-going research on the development of a novel tissue 2 
engineering methodology to construct three-dimensional functional tissues by layering 3 
two-dimensional cell-sheets without any biodegradable scaffold (Shimizu et al 4 
2003,Michel et al 1999). This method which utilizes thermosensitive polymer coated 5 
TCPS to harvest the cell-sheets, is aimed at solving some problems faced by 6 
conventional cell seeding technique. Cell-sheets can be easily handled and transplanted 7 
out of the tissue culture environment without the use of trypsin, onto the scaffolds and 8 
other tissue engineering constructs (Kikuchi et al 1998). There have been studies done on 9 
the benefits of the use of these thermosensitive plates and it is reported that thermal 10 
liftoff of the cell-sheet is less damaging to the ECM proteins (Canavan et al 2005) as 11 
compared to conventional cell-sheet detachment protocols. However this process is 12 
currently performed mostly on terminally differentiated cells (Matsuda et al 2007).  13 
 14 
Fig 1d: Diagram representing thermosensitive polymer based cell-sheet detachment vs 15 
conventional enzymatic disruption of cell adhesion and cell-cell proteins. Image taken 16 
from www.jst.go.jp/EN/seika/01/seika15.html 17 
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These differentiated cells have limited lifespan, poor proliferation potential and 1 
require long period of culture time to obtain a cell-sheet with ECM that can be handled 2 
and manipulated without breaking apart. Therefore, growing BMSC cell-sheets that 3 
possess multilineage differentiation capability would be beneficial for various tissue 4 
engineering applications. Although studies have already shown that BMSC cell-sheets 5 
are able to, improve cardiac function after an infarction (Wang et al 2008), enhance bone 6 
formation (Nakamura et al 2010,Ouyang et al 2006) and engineer nasal alar cartilage 7 
(Zhang et al 2009), however the retention of the multilineage potential of the BMSC cell-8 
sheets used in the studies have not been validated. 9 
 10 
 24 
Tissue Engineering Approaches to IVD Regeneration  1 
. In IVD tissue engineering, the aim is to induce regeneration of the tissue in situ 2 
by biological manipulation or to develop a functional tissue construct in vitro that is able 3 
to be implanted into the body which will be able to restore normal physiological function. 4 
Since the mechanical properties of the IVD are closely related to the ECM components, 5 
tissue engineering methods are mostly focused on regenerating the ECM components of 6 
the IVD to restore its function. 7 
The state of degeneration of the IVD would determine the treatment strategy used 8 
(An et al 2003). In a situation where the AF still has the mechanical properties to 9 
withstand bulging pressures, a strategy targeted at regenerating only the NP would be 10 
appropriate. The tension within the AF attributed to the bulging of the NP would induce 11 
regeneration of the AF fibres. In cases where the AF has degenerated beyond its own 12 
ability for self repair, an implant of a tissue engineered in vitro construct consisting of a 13 
functional NP and AF would be more suitable. Most studies targeted at regenerating a 14 
functional IVD involve using AF cells, NP cells or BMSCs seeded onto various scaffolds 15 
and cultured in vitro to access cell viability and various ECM component deposition. 16 
There are also a few studies that apply a mechanical stimulus to stimulate the appropriate 17 
ECM production. 18 
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Cell Source for IVD Tissue Engineering 1 
 By conventional tissue engineering strategies, using autologous IVD cells would 2 
be an attractive source to produce a functional IVD construct. However, obtaining 3 
sufficient numbers of NP or AF cells provides a great challenge, this is due to the low cell 4 
viability (Boos et al 2002), low cell numbers and low proliferative capability (Roberts et 5 
al 2006,Le Maitre et al 2007,Gruber et al 2009) of these cells during cultivation. 6 
Moreover, obtaining these cells would involve taking a biopsy of a healthy IVD from 7 
which to extract the cells, which would mean puncturing the AF and NP thereby 8 
damaging structure and mechanical function. This method resembles protocols used to 9 
induce IVD degeneration in animal experiments (Alini et al 2008). Thus alternative cell 10 
sources are needed. 11 
 Notochordal cells are present in the embryonic human NP (Hunter et al 2003). 12 
These cells are involved in regulating the biosynthetic activity of the NP cells, however, 13 
their numbers diminish rapidly soon after birth and by the first decade, they have all 14 
disappeared. It has been reported that their disappearance coincides with the early onset 15 
of IVD degeneration (Aguiar et al 1999). It has been shown in animal models that these 16 
cells cultured together with mature NP cells increase their proteoglycan production 17 
(Aguiar et al 1999), and would be promising if it could be translated to the human model. 18 
Unfortunately, there is no human source for these cells available (Hunter et al 2003). 19 
 Autologous adult mesenchymal cells can be obtained in larger amounts from the 20 
bone marrow (BMSCs) or from adipose tissue. These cells have been shown to possess 21 
self-renewing capacity and can differentiate into osteocytes, chondrocytes, adipocytes, 22 
tenocytes, and nerve or muscle cells (Dezawa 2008,Lin et al 2008,Wang et al 2005,Banfi 23 
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et al 2000,Pittenger et al 1999). These cells also possess the capability to produce 1 
abundant amounts of ECM (Ge et al 2005,Van Eijk et al 2004). There have been no 2 
reports on any specific markers for AF and NP cells, but it has been reported that 3 
mesenchymal stem cells adopted a gene expression profile that resembled native IVD 4 
tissue (Steck et al 2005). There has also been studies that have  showed that coculturing 5 
human NP cells and human BMSCs caused the BMSCs to differentiate to NP-like 6 
phenotype cells (Richardson et al 2006). A study done by Sakai et al. found that rabbit 7 
BMSCs embedded in Atelocollagen gel was effective in slowing down disc degeneration 8 
in rabbits (Sakai et al 2003) and Risbud et al. reported that hypoxia and transforming 9 
growth factor β initiated differentiation of rat BMSCs along the chondrogenic lineage, 10 
possibly acquiring the phenotype and characteristics of NP-like cells (Risbud et al 2004). 11 
Thus, these cells may represent an attractive source from which to obtain IVD-like cells. 12 
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Signals for IVD Tissue Engineering 1 
 Studies have shown that introducing exogenous growth factors into the NP region 2 
have been shown to increase cell population (Walsh et al 2004) and restore (Imai et al 3 
2007) or even increase disc height (An et al 2005). However, the main limitation of using 4 
exogenous growth factors is that half lives of these proteins (Wallach et al 2003). 5 
Therefore, gene therapy, which is to transfer genes to recipient cells so that they 6 
synthesize RNA and protein they encode to induce a sustained secretion of endogenous 7 
growth factors, is becoming more prominent (Nishida et al 2008). Gene delivery systems 8 
can be divided into in vitro and in vivo treatments. The in vitro treatment requires 9 
harvesting of the IVD cells and transduction of the gene before re-implanting them into a 10 
degenerate IVD and the in vivo method involves transduction of the cells in situ 11 
(Cassinelli et al 2001). The latter would alleviate the problem of harvesting and culturing 12 
and re-implanting the cells. Originally, gene therapy was performed using viral vectors, 13 
but recent advanced has enabled a non-virus-mediated gene therapy (Nishida et al 2006) 14 
to be used for the disc. Thus, gene therapy would be a viable option to consider in IVD 15 
tissue engineering. 16 
 There have been a number of reports using mechanical stimulus to try to achieve 17 
increased IVD cell proliferation, increased mRNA expression and matrix deposition of 18 
the related proteins (Iwashina et al 2006,Miyamoto et al 2005,Wenger et al 2005). It is 19 
hypothesized that stress fibres within the cells detect the mechanical stimulus and adapt 20 
accordingly. The NP cells within the IVD are compressed while the AF cells undergo a 21 
concentric tensile and radial compression stress due to the radial bulging of the NP. 22 
However, most work involving mechanical stimulus uses hydrostatic (Reza, & Nicoll 23 
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2008) and hydrodynamic (Gokorsch et al 2004) pressure on IVD cells. These methods of 1 
application of mechanical stimulus do not accurately represent the physiological 2 
conditions experienced within the body.  3 
 29 
Scaffolds for IVD Tissue Engineering 1 
 In tissue engineering, scaffolds serve the purpose to mimic the ECM in the body. 2 
It is also used to provide a conducive cell adhesion environment, temporary mechanical 3 
support for the cells or to provide biochemical signals if required to promote tissue 4 
ingrowth. For the case of IVD tissue engineering, different scaffolds will have to be used 5 
in order to achieve the appropriate mechanical properties required of the NP and the AF. 6 
 There have been many reports using freeze dried atellocollagen (Sato et al 2003), 7 
collagen (Rong et al 2002,Sun et al 2001), polyglycolic acid (Mizuno et al 2004), agarose, 8 
alginate, fibrin gels (Gruber et al 1997) or silk (Chang et al 2007) as scaffolds for the NP 9 
and AF.  Most reports use assessment methods like increased DNA, increased 10 
proteoglycan synthesis and gene expression to determine the suitability of the scaffold for 11 
IVD tissue engineering. For scaffolds used to study NP regeneration, despite the reports 12 
of increased DNA and ECM deposition, there was little mention on these scaffolds 13 
having the viscoelastic properties of the native NP. Studies on scaffolds for the AF report 14 
mostly collagen type II and aggrecan production instead of collagen type I, which is the 15 
more common ECM found in the native outer AF. The larger quantity of collagen type II 16 
deposited might suggest that the scaffolds would be more suitable for engineering the 17 















2.  RATIONALE 1 
 Based on the current literature, arthrodesis is the current gold standard to relief 2 
pain from patients suffering from DDD, but it does not aim to regenerate the damaged 3 
tissue. Recently, much work has been done in an attempt to find suitable tissue 4 
engineered replacements to regenerate the IVD. There have been promising reports on 5 
NP replacements, however one of the limitations have been the lack of effective 6 
strategies to regenerate the AF. 7 
 8 
2.1 Hypothesis 9 
 The AF consists of many distinct lamellae of dense ECM capable of withstanding 10 
the bulging pressure of the NP. BMSC cell-sheets seeded onto silk scaffolds have the 11 
potential to mimic the native lamellae structure of the AF and subjected to mechanical 12 
stimulation in a bioreactor, the assembly can successfully regenerate the appropriate 13 
ECM. 14 
 15 
2.2 Objectives 16 
 The main aim of this project was to use BMSC cell-sheets seeded onto a 17 
combined freeze dried/knitted silk scaffolds, wrapped around a cylindrical silicone that 18 
simulates the NP and subjected to compression in a bioreactor to potentially develop a 19 
new technique to tissue engineer the AF. 20 
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The specific objectives of this project are to be carried out in 4 phases: 1 
Phase I – Characterization of BMSC Cell-Sheet Growth Profile 2 
(a) The goal is to determine BMSC cell-sheet viability, DNA content, collagen content 3 
and thickness over 3 weeks of hyperconfluent culture 4 
- The information derived from the cell-sheet growth profile would allow the 5 
establishment of a standardized protocol for BMSC cell-sheet culture. 6 
 7 
Phase II – Characterization of BMSC Cell-Sheet Multilineage Potential 8 
(a) The goal is to determine the retention of differentiation capability into adipogenic, 9 
chondrogenic and osteogenic lineages of the BMSC cell-sheet after 2 weeks post 10 
confluent culture. 11 
- The information obtained from the experiment would determine the viability of BMSC 12 
cell-sheet technology as a cell source for tissue engineering of more complex tissues that 13 
would involve more than 1 cell type. 14 
 15 
Phase III - Fabrication and Verification of Simulated IVD-like Assembly Viability 16 
(a) The goal is to determine a protocol for fabricating a simulated NP using silicone 17 
- The protocol would allow us to attempt to control the material properties of a 18 
viscoelastic material that would be used to simulate the NP for the IVD-like assembly. 19 
 20 
(b) The goal is to fabricate the IVD construct using BMSC cell-sheets and knitted/freeze 21 
dried combined silk scaffold to simulate the lamellae of the AF wrapped around the 22 
cylindrical silicone NP obtained from (a). 23 
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- The results would let us determine if the cell-sheet within the construct would remain 1 
viable through long term culture. 2 
 3 
Phase IV – Fabrication of Compression Bioreactor to provide Mechanical Stimulus 4 
to IVD Assembly 5 
(a) The goal is to design and fabricate a bioreactor unit that is capable of applying 6 
physiological loading to the IVD-like assembly 7 
- The bioreactor would allow a compressive force to be applied to the silicone NP. The 8 
simulated NP would then bulge radially and press onto the BMSC cell-sheets and silk 9 
scaffolds wrapped around it, thus stretching the assembly circumferentially. This would 10 
allow us to study the effects on the BMSC cell-sheet and determine the feasibility of the 11 
assembly to be used for AF tissue engineering in the future. 12 
 13 
 All the above mentioned objectives would lead the way to determine whether 14 
hyperconfluent cultures would affect the multipotency of BMSC cell-sheets and its 15 
feasibility to be used as a cell source together with silk scaffolds and a silicone simulated 16 
NP, to create an IVD construct as a novel method of AF tissue engineering. 17 
 18 
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2.3 Overview 1 
 As described in Section 2.2, the listed objectives of this project were carried out in 2 
4 phases, shown diagrammatically in Figure 2.1 3 
 4 
Fig 2.1: Flowchart illustrating the outline and flow of research 5 
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3.1 Phase I – Fabrication and Characterization of BMSC Cell-Sheet 1 
3.1.1 Bone Marrow Isolation from New Zealand White Rabbits 2 
 Rabbit BMSCs were isolated from bone marrow aspirates which were obtained 3 
from New Zealand White Rabbits (approximately 8 weeks old). The BMSCs were then 4 
isolated from the red blood cells and plasma by differential migration during 5 
centrifugation using Ficoll-Paque PLUS (GE Healthcare). 3ml of Ficoll-Paque PLUS was 6 
added to a 15ml centrifuge tube and 4ml of blood was carefully layered on top to ensure 7 
the 2 layers do not mix. The tube is then centrifuged at 400xg for 40 minutes at 18oC. The 8 
BMSCs are found in the lymphocyte layer between the plasma and Ficoll-Paque PLUS. 9 
The lymphocyte layer is removed and placed in a clean centrifuge tube and diluted with 3 10 
volumes of 1xPBS. The tube is then centrifuged at 100xg for 10 minutes at 18oC causing 11 
the cells to pellet. The supernatant was removed and discarded and 8ml of 1xPBS was 12 
used to resuspend the cells. The tube is again centrifuged at 100xg for 10 minutes at 18oC. 13 
The supernatant was removed and the cells resuspended in 1ml of low glucose culture 14 
medium Dulbecco’s modified Eagle’s medium (LG-DMEM; Gibco, Invitrogen, CA), 15 
supplemented with 15% v/v fetal bovine serum (HyClone, Logan, UT), penicillin and 16 
streptomycin and plated on TCPS to allow the BMSCs to adhere and maintained at 37oC 17 
in an incubator with 5% humidified CO2. 18 
 19 
3.1.2 BMSC Culture 20 
a. Expansion of BMSCs 21 
When primary BMSCs became near confluent, they were detached using trypsin 22 
(0.25%) /1mM ethylenediamine-tetraacetic acid (EDTA) and re-plated with a ratio of 1:3 23 
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in low glucose culture medium Dulbecco’s modified Eagle’s medium (LG-DMEM; 1 
Gibco, Invitrogen, CA), supplemented with 15% v/v fetal bovine serum (HyClone, Logan, 2 
UT), penicillin and streptomycin. The cultures were replenished with fresh medium at 3 
37oC every 3-4 days. 4 
 5 
b. Freezing of excess BMSCs 6 
Excess BMSCs were detached and counted. The BMSCs were split into aliquots 7 
of 1x106 cells. Cell freezing medium was made with dimethyl sulfoxide (DMSO), fetal 8 
bovine serum and blank LG-DMEM in the ratio 1:2:7. The freezing medium was cooled 9 
to 4oC prior to introducing the cells. Each aliquot of BMSCs was resuspended in 1ml of 10 
freezing medium and immediately placed into a freezing container filled with isopropanol, 11 
and placed into a -80oC freezer. After 2 hours, the BMSCs were transferred into liquid 12 
nitrogen for long term storage.  13 
 14 
3.1.3 Seeding of BMSCs onto 6-well TCPS 15 
BMSCs were seeded at a density of 3 x 105 cells/well in wells of a non-treated 6-16 
well culture plate (NUNC, Denmark). The cells were cultured in-vitro in a 5% CO2 17 
incubator at 37oC till the cells reached 100% confluence (Day 0).  18 
 19 
3.1.4 Fabrication Methods of BMSC Cell-Sheet 20 
a. L-Ascorbic Acid supplement 21 
At Day 0, the confluent cells were supplemented with 50µg/ml L- Ascorbic Acid 22 
(L-Asc) (Wako, Japan) in LG-DMEM. . The cultures were replenished with fresh L-Asc 23 
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supplemented medium at 37oC every 3-4 days and cultured till the desired time point. L-1 
Asc was added to improve collagen production (Hata, & Senoo 1989) so as to obtain a 2 
more stable cell-sheet. 3 
 4 
b. L-Ascorbic Acid with Dextran Sulphate supplements 5 
 Dextran sulphate (DexS) is an inert, negatively charged macromolecule. It has 6 
been shown that crowding using these macromolecules (also known as macromolecular 7 
crowding, MMC) improves the rate of conversion of procollagen to insoluble collagen in 8 
terminally differentiated cell lines (Lareu et al 2007). 9 
Various experiments were done using DexS as a macromolecular crowder. The 10 
aim of the experiments was to determine if supplementing media with dextran sulphate 11 
would improve the efficiency of collagen type I deposition, thereby creating a more 12 
robust cell-sheet layer. DexS (500kDa; pK Chemicals A/S, Koge, Denmark), when 13 
supplemented to the L-Asc media, was always done after confluence, and at a 14 
concentration of 100µg/ml for 2 days. 15 
 16 
3.1.5 Investigation on the Suitability of DexS to Aid BMSC Cell-Sheet Formation 17 
a. SDS-PAGE Collagen Type I Quantification  18 
The 1st experiment was done to determine if the concept of MMC works with 19 
BMSCs. Once the cells had reached confluence, half the wells were supplemented with 20 
L-Asc only, and the remaining was supplemented with both L-Asc and DexS. The 21 
cultures were maintained for 2 days before they were sacrificed for SDS-PAGE collagen 22 
type I quantification. 23 
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The 2nd experiment was done to determine if MMC can work on BMSCs in long 1 
term culture. The experiment was done up to 9 days post confluence with different 2 
culture conditions to determine the effects of MMC on BMSCs. The different culture 3 
conditions are illustrated below in Figure 3.1.5a. 4 
 5 
Fig 3.1.5a: Illustration of experimental timeline with and without DexS 6 
 7 
The hyperconfluent cell-sheets were washed twice with 1xPBS after the Alamar 8 
Blue assay and digested with porcine gastric mucosa pepsin (2500 U/mg; Roche 9 
Diagnostics Asia Pacific, Singapore) in a final concentration of 0.25mg/mL. Samples 10 
were incubated at room temperature (RT) for 1h with gentle shaking followed by 11 
sonication of the solution until all cell fragments have broken up followed by 1hr 12 
incubation at RT. After the incubation step, the samples were neutralized with 0.1 N 13 
NaOH. The samples were analyzed by SDS-PAGE under non-reducing conditions (See et 14 
al 2008). A SDS gel made up of 3% stacking and 5% resolving components were used 15 
(Appendix A2). The gel was run at 50V for 30 minutes and 120V for 60 minutes. 16 
Collagen bands were stained using SilverQuest kit (Invitrogen, Carlsbad, CA) according 17 
to the manufacturer’s protocol (Appendix A3). Densitometric analysis of wet gels was 18 
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performed on the GS-800 Calibrated Densitometer (Bio-Rad Laboratories, Hercules, CA) 1 
with the Quantity One v4.5.2 image analysis software (Bio-Rad Laboratories, Hercules, 2 
CA). 3 
 4 
b. Alamar Blue Cell-Sheet Viability Assessment between DexS and non DexS treated 5 
Cell-Sheets 6 
The experiment was done to determine if MMC had any effects on the viability of 7 
the BMSCs as compared to the non-MMC treated cells. The viability of the cells present 8 
within the hyperconfluent cell-sheets was determined using the Alamar Blue colorimetric 9 
assay (Invitrogen, CA). The cells were incubated in medium supplemented with 20% (v/v) 10 
Alamar Blue dye for 1 h. One hundred microliters of medium from each sample was read 11 
at 570/600nm in a microplate reader (Sunnyvale, CA). Medium supplemented with 20% 12 
Alamar Blue dye was used as a negative control and the percentage of Alamar Blue dye 13 
reduction was calculated according to the formula stated in Appendix A1. A percentage 14 
reduction of Alamar Blue dye would indicate that the cells assayed are viable. 15 
 16 
3.1.6 Technique to Accurately Quantify Collagen Content in Hyperconfluent 17 
Culture 18 
a. Cell Seeding and Culture 19 
 Both fibroblasts and BMSCs were seeded at a density of 2.5 x 105 cells/well in 20 
wells of a non-treated 6-well culture plate (NUNC, Denmark). The cells were grown in 21 
vitro in a 5% CO2 incubator at 37oC for another 2 weeks (Day 14) after the wells reached 22 
100% confluence (Day 0), with the medium being replaced every 3-4 days. A total of 6 23 
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wells (3 will be sonicated) for each cell type (BMSCs and fibroblasts) at each timepoint 1 
(Day 0 and Day 14) will have their relative cell numbers analyzed before sacrificing for 2 
collagen quantification.  3 
 4 
b. Alamar Blue Analysis of Cell Numbers 5 
The number of cells present within the hyperconfluent cell layers was determined 6 
using the Alamar Blue (Invitrogen, CA) colorimetric assay. Briefly, the cells were 7 
incubated in medium supplemented with 20% (v/v) alamar blue dye for 1 h. One hundred 8 
microliters of medium from each sample was read at 570/600nm in a in a microplate 9 
reader (Sunnyvale, CA). Medium supplemented with 20% Alamar Blue dye was used as 10 
a negative control and the percentage of Alamar Blue reduction was calculated according 11 
to the formula stated in Appendix A1. The cells were subsequently processed to analyse 12 
their collagen content after the Alamar Blue assay. 13 
 14 
c. Sonication to Aid Cell Layer Pepsin Digestion for Collagen Quantification using SDS-15 
PAGE 16 
 The hyperconfluent cell layers were washed twice with 1xPBS after the Alamar 17 
Blue assay and digested with porcine gastric mucosa pepsin (2500 U/mg; Roche 18 
Diagnostics Asia Pacific, Singapore) in a final concentration of 0.25mg/mL. Samples 19 
were incubated at room temperature (RT) for 1h with gentle shaking followed by 20 
sonication of the solution until all cell fragments have broken up followed by 1hr 21 
incubation at RT. For samples that were not sonicated, they were incubated for 2h at RT. 22 
After the incubation step, the samples were neutralized with 0.1 N NaOH. The samples 23 
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were analyzed by SDS-PAGE under non-reducing conditions described in (Raghunath et 1 
al 1994,Lareu et al 2007). Briefly, a 10% homemade SDS gel made up of 3% stacking 2 
and 5% resolving components is used (Appendix A2). Collagen bands are stained using 3 
SilverQuest kit (Invitrogen) according to the manufacturer’s protocol (Appendix A3). 4 
Densitometric analysis of wet gels was performed on the GS-800 Calibrated 5 
Densitometer (Bio-Rad) with the Quantity One v4.5.2 image analysis software (Bio-Rad).  6 
 7 
3.1.7 Investigation of BMSC Cell-Sheet Growth Post-Confluence 8 
a. Alamar Blue Cell-Sheet Viability Assessment 9 
The viability of the cells present within the hyperconfluent cell-sheets was 10 
determined using the Alamar Blue colorimetric assay (Invitrogen, CA). The cells were 11 
incubated in medium supplemented with 20% (v/v) Alamar Blue dye for 1 h. One 12 
hundred microliters of medium from each sample was read at 570/600nm in a microplate 13 
reader (Sunnyvale, CA). Medium supplemented with 20% Alamar Blue dye was used as 14 
a negative control and the percentage of Alamar Blue dye reduction was calculated 15 
according to the formula stated in Appendix A1. A percentage reduction of Alamar Blue 16 
dye would indicate that the cells assayed are viable. 17 
 18 
b. SDS-PAGE Collagen Type I Quantification 19 
 The BMSC cell-sheets were cultured till 3 weeks post confluence, and at each 20 
weekly time point, the cell-sheets were sacrificed for collagen type I and DNA 21 
quantification. 22 
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The hyperconfluent cell-sheets were washed twice with 1xPBS after the Alamar 1 
Blue assay and digested with porcine gastric mucosa pepsin (2500 U/mg; Roche 2 
Diagnostics Asia Pacific, Singapore) in a final concentration of 0.25mg/mL. Samples 3 
were incubated at room temperature (RT) for 1h with gentle shaking followed by 4 
sonication of the solution until all cell fragments have broken up followed by 1hr 5 
incubation at RT. After the incubation step, the samples were neutralized with 0.1 N 6 
NaOH. The samples were analyzed by SDS-PAGE under non-reducing conditions (See et 7 
al 2008). A SDS gel made up of 3% stacking and 5% resolving components were used 8 
(Appendix A2). The gel was run at 50V for 30 minutes and 120V for 60 minutes. 9 
Collagen bands were stained using SilverQuest kit (Invitrogen, Carlsbad, CA) according 10 
to the manufacturer’s protocol (Appendix A3). Densitometric analysis of wet gels was 11 
performed on the GS-800 Calibrated Densitometer (Bio-Rad Laboratories, Hercules, CA) 12 
with the Quantity One v4.5.2 image analysis software (Bio-Rad Laboratories, Hercules, 13 
CA). 14 
 15 
c. Immunofluorescence for Cell-Sheet Thickness Assessment using Confocal Microscopy 16 
 Cell-sheets were fixed in -20oC methanol for 10 minutes and washed with 1xPBS. 17 
A 3% BSA (w/v), dissolved in 1xPBS was added to block the sample for 30 minutes at 18 
25oC. The BSA was removed and a mouse anti collagen type I antibody (1:4000, 19 
SigmaAldrich, San Louis, MO) was incubated on the sample for 90 minutes at 25oC. The 20 
samples was washed in 0.05% Tween 20 (v/v) in 1xPBS for 20 minutes and incubated 21 
with goat anti mouse Alexa Fluor 594 (1:400, Invitrogen, Carlsbad, CA) and DAPI 22 
(1:800, Invitrogen, Carlsbad, CA) for 30 minutes at 25oC. The samples was washed in 23 
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0.05% Tween 20 (v/v) in 1xPBS for 20 minutes before confocal microscopy (Olympus 1 
FluoView Confocal Laser Scanning Microscopes, FV500). To determine the thickness of 2 
the cell-sheet, the z-direction slicing mode was used and average of 9 points around the 3 
well was taken. 4 
 5 
d. DNA Quantification 6 
 DNA content measured spectrophotometrically using the Hoechst 33258 method 7 
(Toh et al 2005). The fluorescence measurement of Hoechst 33258 dye was performed 8 
using a fluorescence plate reader (FLUOstar Optima, BMG Labtechnologies, Offenburg, 9 
Germany). Calf thymus DNA was used for construction of the standard curve for DNA 10 
quantification. 11 
 12 
e. SEM Analysis 13 
Some 2-week old cell-sheets were coated with gold using a Sputter Coater (BAL-14 
TEC Inc) and their morphology was observed by scanning electron microscopy (SEM, 15 
JEOL JSM-5600LV, Japan) operated at a voltage of 10kV. 16 
 17 
3.1.8 Statistical Analysis 18 
 All data is expressed as mean ± standard deviation (SD). All statistical analysis 19 
was performed by pair-wise comparison of experimental categories using two-tailed, 20 
unpaired student t-test. A p-value <0.05 was considered significant. Statistical analysis 21 
was performed using Graph Pad Software (San Diego, CA). 22 
 23 
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3.2 Phase II – Characterization of BMSC Cell-Sheet Multipotentiality and 1 
Comparison between Conventional BMSC Differentiation Protocols 2 
3.2.1 BMSC Cell-Sheet Culture 3 
 BMSCs were seeded at a density of 3 x 105 cells/well in wells of a non-treated 6-4 
well culture plate (NUNC, Denmark) for osteogenic and adipogenic differentiation 5 
cultures. For chondrogenic differentiation, 7 x 104 BMSCs were seeded/well in wells of a 6 
non-treated 24-well culture plate (NUNC, Denmark). The cells were cultured in-vitro in a 7 
5% CO2 incubator at 37oC till the cells reached 100% confluence (Day 0). Following that, 8 
the confluent cells were supplemented with 50µg/ml L- Ascorbic Acid (L-Asc) (Wako, 9 
Japan) in LG-DMEM for 2 weeks before the cell-sheets were differentiated into 10 
chondrogenic, adipogenic and osteogenic lineages. 11 
 12 
3.2.2 Media Preparation and Culture Conditions for Differetiation of BMSC Cell-13 
Sheets 14 
a. Adipogenic Differentiation Medium and Culture 15 
 LG-DMEM was removed from the 14 day BMSC cell-sheet culture wells and 16 
replaced with adipogenic induction media made up of 15% FBS high glucose DMEM 17 
(HG-DMEM) supplemented with  0.5 mM isobutyl-methylxanthine (Aldrich, Milwaukee, 18 
WI), 10 µM bovine insulin, 1 µM dexamathasone, and 200 µM indomethacin (Sigma-19 
Aldrich, St Louis, MO). The adipogenic differentiation was stimulated using 3 cycles of 20 
induction media for 4 days and maintenance media for 3 days. Maintenance media only 21 
consisted of 15% FBS in HG-DMEM. Control group wells were also cultured in 22 
maintenance media throughout. An experiment was also carried out at the start of the 23 
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induction cycle, when the culture reached hyperconfluence. This would provide a 1 
comparison between the CSI and CI cultures. The cultures were incubated at 37oC in 5% 2 
CO2 over a period of 3 weeks. The culture medium was changed every 3-4 days. 3 
 4 
b. Chondrogenic Differentiation Medium and Culture 5 
 The 14-day BMSC cell-sheets were induced to roll up into a pellet by agitation of 6 
the sides of the cell-sheet. The cell-sheet pellets was transferred into 15ml polypropylene 7 
falcon tubes and supplemented with chondrogenic induction media as described in (Wu et 8 
al 2007). High glucose DMEM supplemented with 15% FBS, 10-7M dexamethasone, 50 9 
µg/ml L-Ascorbic acid, 4mM proline, (all from Sigma-Aldrich, St Louis, MO), 1% ITS+ 10 
premix (BD Bioscience Inc. Franklin Lakes, NJ), and 1mM sodium pyruvate was used as 11 
the chondrogenic induction media. Chondogenic differentiation was induced in the 12 
presence of 10 ng/ml Transforming Growth Factor β3 (TGF-β3) (RayBiotech Inc. 13 
Norcross, Georgia) while controls were not supplemented with TGF-β3. The 14 
differentiation capability of the cell-sheet pellets was compared to those using the well 15 
established conventional protocols for chondrogenic differentiation (Indrawattana et al 16 
2004). This would provide a comparison between the cell-sheets induced (CSI) cultures 17 
and conventional induced (CI) cultures and also their respective non-induced (NI) control 18 
cultures. The pellets were incubated at 37oC in 5% CO2 over a period of 3 weeks. 19 





c. Osteogenic Differentiation Medium and Culture 1 
LG-DMEM was removed from the 14-day BMSC cell-sheet culture wells and 2 
replaced with osteogenic differentiation media. The osteogenic differentiation media was 3 
made up of 15% FBS HG-DMEM supplemented with 10-8M dexamathasone, 50µM L-4 
Ascorbic acid and 10mM β-glycerolphosphate (Sigma-Aldrich, St Louis, MO) and 5 
25ng/ml Bone Morphogenic Protein 2 (BMP2) (RayBiotech Inc. Norcross, Georgia). 6 
Control group wells were cultured with only 15% FBS in HG-DMEM. In addition, an 7 
experiment was done using a seeding density of 3 x 104 cells/well and induction media 8 
was introduced the following day. This would provide a comparison between the CSI and 9 
CI cultures. The cultures were incubated at 37oC in 5% CO2 over a period of 4 weeks. 10 
Medium was changed every 3-4 days. 11 
 12 
3.2.3 Histological Assessment of Differentiation  13 
a. Histochemical staining of Adipocytes 14 
Oil Red O staining technique was used to evaluate adipogenesis. Neutral lipid 15 
droplets found within adipocytes were stained with Oil Red O (Sigma-Aldrich, St Louis, 16 
MO). A stock solution was made with 0.5% w/v dye in Isopropanol (IPA). The working 17 
solution was used to stain the lipid droplets. The working solution was made with 6ml of 18 
stock diluted and 4ml ddH2O. The cell-sheets were washed with 1xPBS twice and fixed 19 
with 70% ethanol for 20 sec. The cell-sheets were then stained with the working solution 20 
for 15 min. Excess dye was washed off with 70% ethanol followed by ddH2O. The cells 21 
were then counterstained with hematoxylin for 30 sec and washed. The bright red lipid 22 
droplets were imaged using a brightfield microscope. 23 
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b. Histological and Immunohistochemical assessment of pellet cultures 1 
The pellets were washed in 1xPBS, fixed in 10% neutral buffered formalin 2 
overnight and then embedded in paraffin. 5 µm thick sections were cut and collected on 3 
silane-coated slides for histological and immunohistochemical analysis. The Safranin 4 
O/fast green staining technique was performed as follows: after deparaffinization and 5 
rehydration, the samples were stained for 3 min with iron hemotoxylin, washed for 3 min 6 
with ddH2O, stained for 3 min with fast green. They were washed in acetic acid for 5 sec 7 
and stained for 3 min with Safranin O. The slides were dehydrated before application of a 8 
coverslip.  9 
Immunohistochemistry study was carried out as follows: after deparaffinization 10 
and rehydration, endogenous peroxidase in the samples was first blocked with hydrogen 11 
peroxide for 15 min before pepsin treatment for 20 min. Monoclonal antibodies of 12 
collagen type I (Sigma-Aldrich, St Louis, MO) of dilution factor 1:500, collagen type II 13 
(Chemicon Inc., Temecuela, CA) of dilution factor 1:500; and control mouse IgG isotype 14 
(Zymed Laboratories Inc. San Francisco, CA) of dilution factor 1:2500 were applied for 15 
an hour followed by incubation with biotinylated goat anti-mouse (Lab Vision 16 
Corporation, Fremont, CA) for 30 min. Streptavidin peroxidase was added for 45 min and 17 
3,30-diaminobenzidine was used as a chromogenic agent and counterstaining was done 18 
with hematoxylin. Between each step, the slides were washed with 1xPBS. The slides 19 





c. Histochemical staining of Osteocytes 1 
Alizarin red S staining was used to evaluate osteogenesis. Briefly, Alizarin red S 2 
(ARS) (Sigma-Aldrich, St Louis, MO) stains calcium deposits to confirm osteogenesis. 3 
The cell-sheet was washed with 1xPBS and fixed in 10% Formalin for 30 min. The cells 4 
were washed thoroughly and stained with 40mM ARS for 5 min. Excess dye was washed 5 
off thoroughly with ddH2O and incubated with 1xPBS for 5 min. The orange-red calcium 6 
deposits were imaged using a brightfield microscope. 7 
 8 
3.2.4 RNA Extraction and Real-Time PCR Analysis of Differentiation  9 
 Total RNA was extracted using Trizol® reagent (Invitrogen, Grand Island, NY) 10 
and purified using the RNeasy Mini Kit (Qiagen, Valencia, CA). RNA concentration was 11 
determined using NanoDrop (NanoDrop Technologies, Wilmington, DE) and 12 
complementary DNA synthesis was carried out using 100 ng of total RNA according to 13 
the manufacturer’s protocol for SuperScript II reverse transcriptase with oligo(dT) 14 
primers. Real-Time PCR was done using 2µl of cDNA, 10µl of SYBR Green Master Mix 15 
(Qiagen, Valencia, CA) and the optimized concentration of primers, topped up to 20µl 16 
with nuclease free water. All reactions were performed on the real-time Mx3000P 17 
(Stratagene, CA, USA). The thermal cycling program for all PCRs was the following: 18 
95ºC for 15 min, followed by 40 cycles of amplifications, consisted of denaturation step 19 
at 94ºC for 15 sec, an annealing step at 55ºC for 30 sec and an extension step at 72ºC for 20 
30 sec. The genes analysed were Sox9, collagen type II (Col II) and aggrecan for 21 
chondrogenesis, Peroxisome Proliferator-Activated Receptor (PPARγ2), adipocyte 22 
binding protein 2 (aP2) and leptin for adipogenesis and Runt related transcription factor 2 23 
 50 
(Runx2), collagen type I (Col I), osteopontin (OPN) and osteonectin (ON) for 1 
osteogenesis. Primer sequence for GAPDH and Collagen Type I (Col I) were previously 2 
described (Fan et al 2008). Remaining primers were designed using the Oligo 6.0 3 
program and are listed in Table 3.2.4. The level of expression of the target gene, 4 
normalized to GAPDH, was then calculated using the 2∆Ct formula (Livak, & Schmittgen 5 
2001) with reference to the respective control groups which are set to 1. 6 
 7 




Sox9 F: 5’ CTT CAT GAA GAT GAC CGA CGA G 3’ 
R: 5’ CTC TTC GCT CTC CTT CTT GAG G 3’ 





F: 5’ AAG AGC GGT GAC TAC TGG ATA G 3’ 
R: 5’ TGC TGT CTC CAT AGC TGA AGT 3’ 
214bp   
 
D83228 
Aggrecan F: 5’ GTG AAA GGT GTT GTG TTC CAC T 3’ 




aP2 F: 5’ TTG ATG AAG TCA CCG CAG AT 3’ 
R: 5’ CAT TCC ACC ACC AGT TTA TCA C 3’ 
142bp   
 
AF136241 
PPARγ2 F: 5’ CCT GGC AAA GCA CTT GTA TGA 3’ 
R: 5’ AAC GGT GAT TTG TCT GTC GTC T 3’ 
102bp   
 
AY166780 
Runx2 F: 5’ CCT TCC ACT CTC AGT AAG AAG A 3’ 
R: 5’ TAA GTA AAG GTG GCT GGA TAG T 3’ 
143bp AY598934 
Osteopontin F: 5’ GCT CAG CAC CTG AAT GTA CC 3’ 
R: 5’ CTT CGG CTC GAT GGC TAG C 3’ 
249bp D16544 
Osteonectin F: 5’ GAA GTT GAG GAA ACC GAA GA 3’ 
R: 5’ GGC AGG AGG AGT CGA AG 3’ 
199bp AF247647 
 8 
Table 3.2.4: Custom-Made Primer Sequences for Assessment of Differentiation 9 
 10 
3.2.5 Statistical Analysis 11 
 All data is expressed as mean ± standard deviation (SD). All statistical analysis 12 
was performed by pair-wise comparison of experimental categories using two-tailed, 13 
unpaired student t-test. A p-value <0.05 was considered significant. Statistical analysis 14 
was performed using Graph Pad Software (San Diego, CA). 15 
 51 
3.3 Phase III – Fabrication and Verification of Simulated IVD-like Construct 1 
Viability 2 
3.3.1  Fabrication of Silicone Nucleus Pulposus 3 
 The silicone NP disc with a diameter of 12mm and a height of 9mm was 4 
fabricated using a stainless steel mold (Fig 3.3.1). The silicone mixture of 20:1 (v/v) 5 
silicone:elastomer (Dow Corning Corporation, Midland, MI) was well mixed and left for 6 
60mins at 25oC at 6 torr. The mixture was then poured into the mold and left for 60mins 7 
at 25oC at 6 torr. After the remaining bubbles have escaped, the mold was transferred to 8 
cure for 18 hours at 100oC. 9 
 10 
Figure 3.3.1: Stainless steel mold (left) and silicone NP (right) 11 
 12 
3.3.2  Characterization of Silicone Nucleus Pulposus 13 
 Mechanical testing on the silicone discs was done using the Instron 3345 machine 14 
(Figure 4.3.2). A 100 N load cell was used performed at a rate of 1.125 mm/sec. A 15 
preload of 0.05 N was set before experiments were conducted. The mechanical tests were 16 
separated into many stages. 17 
 52 
 1 
Fig 3.3.2: Instron 3345 machine used to compress and  2 
characterize the silicone NP substitute 3 
 4 
 5 
a. Calculation of Young’s Modulus  6 
 After 2 conditioning cycles of compression on the silicone NP, the data of the 3rd 7 
cycle was recorded by the Instron 3345 machine. A graph of stress vs strain was plotted 8 
from the data recorded by the Instron 3345 machine (Fig 3.3.2a). A best fit curve was 9 
obtained using a cubic equation. By substituting a strain value into the differential of the 10 
best fit cubic equation, we were able to obtain the Young’s Modulus of the silicone NP at 11 
that particular strain. To standardize the mechanical testing data for characterization of 12 




Fig 3.3.2a: An example of a stress vs strain graph obtained from the Instron 3345. The 2 
Young’s Modulus was obtained at the point of 25% compressive strain to standardize 3 
mechanical testing data. 4 
 5 
b. Calculation of Swelling Pressure (Hoop Stress) of Silicone NP 6 
 A close up photo of the silicone NP was taken with a CASIO EX-Z50 camera 7 
before and after compression (Fig 3.3.2b). The width of the disc before and after 8 
compression was measured using the Image J software (http://rsbweb.nih.gov/ij/). The 9 
transverse strain was then calculated by taking the ratio of the maximum change in width 10 
after compression over the original width of the silicone disc. To obtain the hoop stress at 11 
a particular axial compression, the generalized Hooke’s law was used: 12 
 13 
εθ =    [ σθ – v(σr + σa)]  1 
 E 
E: Young’s Modulus 
ν: Poisson’s ratio 
ε: Strain 
σ: Stress 
θ: Circumferential Direction 
r: Radial Direction 






We assume σr to be 0, σa is obtained from the Instron 3345, E is calculated as stated in 1 
4.3.2a, ν and εθ are calculated using the Image J software. 2 
 A study by Glover et al. showed that the swelling pressure of the NP of a porcine 3 
model was 0.05MPa (Glover et al 1991). Thus, the objective of this experiment was to 4 
determine the axial compression that would give a 0.05MPa swelling pressure of the 5 
silicone NP. Following that, another 4 discs from the same batch were subjected to the 6 
same axial compression to determine the pooled average swelling pressure. 7 
 8 
 9 
Fig 3.3.2b: silicone disc before (left) and after (right) compression 10 
 11 
c. Effects of Ethylene Oxide Sterilization on the Mechanical Properties of the Silicone NP 12 
 The silicone discs underwent 25% axial compression before and after ethylene 13 
oxide sterilization. The Young’s modulus of the disc at 25% axial compression was used 14 
to determine if this method of sterilization would have an effect on the mechanical 15 
properties on the silicone disc. 16 
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d. Effects of Cyclic Loading on the Mechanical Properties of the Silicone Nucleus 1 
Pulposus 2 
 2 batches of 5 silicone discs each were subjected to 25% compression at a rate of 3 
0.25 Hz for 30 minutes each day, with a 1 second interval between each cycle.  The discs 4 
were then allowed to recover for 23.5 hrs before the compressions were repeated again. 5 
The experiment was carried out for 3 consecutive days, amounting to 360 cycles per day, 6 
or 1080 cycles over 3 days. Mechanical testing was done on the discs each day, before 7 
and after each set of cyclic loading to obtain the Young’s modulus. 8 
 9 
e. Standardizing of Hoop Strain between Batches of Silicone Nucleus Pulposus 10 
 5 silicone discs from each batch were subjected to different percentages of axial 11 
compression to determine the hoop strain experienced. A close up photo of the silicone 12 
NP was taken with a CASIO EX-Z50 camera before and after compression (Fig 3.3.2b). 13 
The width of the disc before and after compression was measured using the Image J 14 
software (http://rsbweb.nih.gov/ij/). The hoop strain was then calculated by taking the 15 
ratio of the maximum change in width after compression over the original width of the 16 
silicone disc. 17 
 18 
3.3.3 Preparing Combined Silk Scaffolds 19 
 The combined silk scaffolds are made up of a knitted silk skeleton with freeze 20 
dried silk covering the large holes within the knitted silk structure. Silk fibres were 21 
knitted using a knitting machine (Fig 4.3.3a) and the loose ends were held by inserting a 22 
K wire (Buhler, Uzwil, Switzerland) through the loops (Fig 4.3.3b). Sceracin, a protein 23 
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coating that causes immunogenic reactions when implanted was removed by boiling the 1 
silk in 0.1% Na2CO3 solution for 60 minutes.  2 
 To make the silk solution for freeze drying, sceracin was removed as stated above 3 
and dissolved in a solution of CaCl2, 99% ethanol and water in a molar ratio of 1:2:8 at 4 
80oC for 15 minutes, to obtain a 10% silk solution. The silk solution was allowed to cool, 5 
put into a dialysis tubing with a molecular weight cut-off of 3500 daltons and dialysed in 6 
ddH2O overnight. The silk solution was filtered before a small amount was characterized 7 
by freeze drying. The silk solution was then diluted to a concentration of 2% and the 8 
knitted silk scaffold immersed, to be freeze dried (Fig 3.3.3c). 9 
 10 
(a)                                               (b)                                           (c) 11 
Fig 3.3.3: (a):Image of knitting machine; (b):Image of knitted silk scaffold; (c):Image of 12 
combined silk scaffold. 13 
 14 
 15 
  16 
3.3.4 Fabrication of the Simulated IVD-like Construct 17 
 Strips of combined silk scaffolds measuring 50mm by 7mm was cut out and was 18 
used as substrates for the BMSC cell-sheets to adhere on and to simulate the lamellae 19 
structure of the AF when wrapped around the silicone NP. 20 
 21 
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a. Harvesting of BMSC Cell-Sheets 1 
 The harvesting of cells from tissue culture polystyrene (TCPS) usually involves 2 
harsh enzymatic conditions or mechanical methods that have deleterious effects on the 3 
cells and extracellular matrix. A method using a temperature responsive polymer, 4 
poly(N-isopropylacrylamide), (poly-NIPAAm) coated on the surface of normal TCPS to 5 
lift off the entire cell sheet would eliminate the problems faced by current cell harvest 6 
methods (Tsuda et al 2005,Okano et al 1995,Kushida et al 1999). 2 week old BMSC cell-7 
sheets were cultured according to the protocol state in Section 4.1.3, but done on TCPS 8 
coated with poly-NIPAAm (Cellseed, Tokyo, Japan). It has been reported that this 9 
method allows the cell sheet to be harvested without any apparent damage to the ECM, 10 
and the cell sheet has improved re-adhesion properties to the new substrate (Canavan et al 11 
2005).  12 
Medium was removed from the well, and a CellShifter (Cellseed, Tokyo, Japan) 13 
was placed on top of the cell-sheet and incubated at 25oC for 5 minutes. A pair of forceps 14 
was used to remove the CellShifter with the cell-sheet attached and transferred to the 15 
combined silk scaffold and left for 1 minute. The CellShifter was removed with a pair of 16 
forceps leaving behind the cell-sheet on the combined silk scaffold. The detached cell 17 
sheet would then be allowed to adhere to the combined silk scaffold.  18 
 19 
b. Assembling the Silk AF and Silicone NP into the Simulated IVD-like Construct 20 
 The silk AF is made up of 3 strips of combined silk scaffold with only the centre 21 
strip having 2 BMSC cell-sheets attached to it, one on each side (Fig 4.3.4b). The 3 strips 22 
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of silk scaffolds would then be wrapped around the silicone NP and a suture be used to 1 





Top View Side View 




3.3.5  Investigation of Simulated IVD-like Construct in Static Culture Conditions 1 
a. Alamar Blue Cell-Sheet Viability Assessment 2 
The viability of the cells present within the simulated IVD-like constructs was 3 
determined using the Alamar Blue colorimetric assay (Invitrogen, CA). The cells were 4 
incubated in medium supplemented with 10% (v/v) Alamar Blue dye for 3 hours. One 5 
hundred microliters of medium from each sample was read at 570/600nm in a microplate 6 
reader (Sunnyvale, CA). Medium supplemented with 10% Alamar Blue dye was used as 7 
a negative control and the percentage of Alamar Blue dye reduction was calculated 8 
according to the formula stated in Appendix A1. A percentage reduction of Alamar Blue 9 
dye would indicate that the cells assayed are viable. 10 
 11 
Fig 3.3.5a: Image of the Simulated IVD-like construct after Alamar Blue assay. Pink 12 
regions show the cell localization, blue regions have no cells. 13 
 14 
b. SDS-PAGE Collagen Type I Quantification 15 
 The simulated IVD-like constructs were washed twice with 1xPBS after the 16 
Alamar Blue assay and digested with porcine gastric mucosa pepsin (2500 U/mg; Roche 17 
Diagnostics Asia Pacific, Singapore) in a final concentration of 0.25mg/mL. Samples 18 
were incubated at room temperature (RT) for 1h with gentle shaking followed by 19 
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sonication of the solution until all cell fragments have broken up followed by 1hr 1 
incubation at RT. After the incubation step, the samples were neutralized with 0.1 N 2 
NaOH. The samples were analyzed by SDS-PAGE under non-reducing conditions (See et 3 
al 2008). A SDS gel made up of 5% stacking and 7% resolving components were used 4 
(Appendix A4). The gel was run at 50V for 45 minutes and 180V for 95 minutes. 5 
Collagen bands were stained using SilverQuest kit (Invitrogen, Carlsbad, CA) according 6 
to the manufacturer’s protocol (Appendix A3). Densitometric analysis of wet gels was 7 
performed on the GS-800 Calibrated Densitometer (Bio-Rad Laboratories, Hercules, CA) 8 
with the Quantity One v4.5.2 image analysis software (Bio-Rad Laboratories, Hercules, 9 
CA). 10 
 11 
c. Histological Staining (H&E, ALcian Blue, Safranin-O) 12 
The constructs were washed in 1xPBS, fixed in 10% neutral buffered formalin 13 
overnight, dehydrated in a progressively increasing ethanol gradient and then embedded 14 
in paraffin. 10µm thick sections were cut and collected on silane-coated slides for 15 
immunohistochemical analysis. Before staning, the sections were rehydrated a 16 
progressively decreasing ethanol gradient. The H&E staining technique was performed as 17 
follows: the samples were staining for 5 minutes with hematoxylin, washed with tap 18 
water and soaked in 0.2% (v/v) ammonium hydroxide for 30 seconds. They were washed 19 
in tap water and soaked in Eosin for 15 seconds. The slides were dehydrated before 20 
application of a coverslip. Alcian Blue staining technique was performed as follows: the 21 
samples where stained for 30 mins with Alcian Blue, washed for 3 min with ddH2O, 22 
stained for 10 min with nuclear fast red and washed for 3 min with ddH2O. The slides 23 
 62 
were dehydrated before the application of a coverslip. Safranin O/fast green staining 1 
technique was performed as follows: the samples were stained for 3 min with iron 2 
hematoxylin, washed for 3 min with ddH2O, stained for 3 min with fast green. They were 3 
washed in acetic acid for 5 sec and stained for 3 min with Safranin O. The slides were 4 
dehydrated before application of a coverslip.  5 
 6 
d. Immunohistochemical Staining for Collagen Type I and Type II 7 
The constructs were washed in 1xPBS, fixed in 10% neutral buffered formalin 8 
overnight and then embedded in paraffin. 10 µm thick sections were cut and collected on 9 
gelatin treated silane-coated slides for immunohistochemical analysis. 10 
Immunohistochemistry study was carried out as follows: after deparaffinization 11 
and rehydration, endogenous peroxidase in the samples was first blocked with hydrogen 12 
peroxide for 15 min before pepsin treatment for 20 min. Monoclonal antibodies of 13 
collagen type I (Sigma-Aldrich, St Louis, MO) of dilution factor 1:500, collagen type II 14 
(Chemicon Inc., Temecuela, CA) of dilution factor 1:500; and control mouse IgG isotype 15 
(Zymed Laboratories Inc. San Francisco, CA) of dilution factor 1:2500 were applied for 16 
an hour followed by incubation with biotinylated goat anti-mouse (Lab Vision 17 
Corporation, Fremont, CA) for 30 min. Streptavidin peroxidase was added for 45 min and 18 
3,30-diaminobenzidine was used as a chromogenic agent and counterstaining was done 19 
with hematoxylin. Between each step, the slides were washed with 1xPBS. The slides 20 




e. DNA Quantification 1 
 DNA content measured spectrophotometrically using the Hoechst 33258 method 2 
(Toh et al 2005). The fluorescence measurement of Hoechst 33258 dye was performed 3 
using a fluorescence plate reader (FLUOstar Optima, BMG Labtechnologies, Offenburg, 4 
Germany). Calf thymus DNA was used for construction of the standard curve for DNA 5 
quantification. 6 
 7 
f. RNA Extraction and Real-Time PCR Analysis 8 
 Total RNA was extracted using Trizol® reagent (Invitrogen, Grand Island, NY) 9 
and purified using the RNeasy Mini Kit (Qiagen, Valencia, CA). RNA concentration was 10 
determined using NanoDrop (NanoDrop Technologies, Wilmington, DE) and 11 
complementary DNA synthesis was carried out using 100 ng of total RNA according to 12 
the manufacturer’s protocol for SuperScript II reverse transcriptase with oligo(dT) 13 
primers. Real-Time PCR was done using 2µl of cDNA, 10µl of SYBR Green Master Mix 14 
(Qiagen, Valencia, CA) and the optimized concentration of primers, topped up to 20µl 15 
with nuclease free water. All reactions were performed on the real-time Mx3000P 16 
(Stratagene, CA, USA). The thermal cycling program for all PCRs was the following: 17 
95ºC for 15 min, followed by 40 cycles of amplifications, consisted of denaturation step 18 
at 94ºC for 15 sec, an annealing step at 55ºC for 30 sec and an extension step at 72ºC for 19 
30 sec. The genes analysed were Sox9, collagen type I (Col I), collagen type II (Col II),  20 
aggrecan, biglycan and decorin. Primer sequence for GAPDH and Collagen Type I (Col I) 21 
were previously described (Fan et al 2008). Remaining primers were designed using the 22 
Oligo 6.0 program and are listed in Table 4.3.5f. The level of expression of the target 23 
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gene, normalized to GAPDH, was then calculated using the 2∆Ct formula (Livak, & 1 
Schmittgen 2001) with reference to the respective control groups which are set to 1. 2 




Sox9 F: 5’ CTT CAT GAA GAT GAC CGA CGA G 3’ 
R: 5’ CTC TTC GCT CTC CTT CTT GAG G 3’ 





F: 5’ AAG AGC GGT GAC TAC TGG ATA G 3’ 
R: 5’ TGC TGT CTC CAT AGC TGA AGT 3’ 
214bp   
 
D83228 
Aggrecan F: 5’ GTG AAA GGT GTT GTG TTC CAC T 3’ 




Biglycan F: 5’ ATG GCC TGA AGC TCA ACT ACC T 3’ 
R: 5’ ATC ATC CGG ATC TGG TTG TG 3’ 
187bp AF020290 
Decorin F: 5’ CCT TCT CTT ACG GAA CTA CAT C 3’ 
R: 5’ TGA AAC TCA GAC CCA ACT TAG 3’ 
103bp U03394.1 
 3 
Table 3.3.5f: Self Designed Primer Sequences for Assessment of 4 
 Genes associated with IVD 5 
 6 
3.3.6 Statistical Analysis 7 
 All data is expressed as mean ± standard deviation (SD). All statistical analysis 8 
was performed by pair-wise comparison of experimental categories using two-tailed, 9 
unpaired student t-test. A p-value <0.05 was considered significant. Statistical analysis 10 
was performed using Graph Pad Software (San Diego, CA). 11 
 12 
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3.4 Phase IV - Bioreactor Studies on Simulated IVD-like Construct 1 
3.4.1 Design Concept of the Bioreactor 2 
 Under physiological conditions, NP cells within the IVD are compressed while 3 
the AF cells undergo a concentric tensile and radial compression stress due to the radial 4 
bulging of the NP. There have been several bioreactor systems designed with the aim to 5 
provide mechanical stimulus for IVD regeneration. However, most work involving 6 
mechanical stimulus uses hydrostatic (Reza, & Nicoll 2008) and hydrodynamic 7 
(Gokorsch et al 2004) pressure on IVD cells. However, these methods of mechanical 8 
stimulus do not accurately represent the physiological conditions experienced within the 9 
body.  Therefore a bioreactor was designed to compress the silicone NP substitute, 10 
causing it to bulge in the radial direction to better mimic the physiological forced 11 
experienced by the AF. 12 
 13 
3.4.2 Development of a Bioreactor to Compress Simulated IVD-like Assembly 14 
 The prototype consists of a water tight chamber and a moving platen to compress 15 
the simulated IVD-like assembly (Fig 3.4.2, see Appendix A5 for detailed Solidworks 16 
drawings). In order for the rotating motor to exert uniaxial compression onto the sample, 17 
a coupling is designed to transform the rotation into uniaxial motion. All the parts were 18 
made of stainless steel except the chamber case which was made up of acrylic. The 19 
bioreactor was made water-tight using rubber O-rings. 20 
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  1 
Fig 3.4.2: Picture of assembled bioreactor (left) and  2 
coupling to transform rotation into linear motion (right) 3 
 4 
a. Software Programming 5 
 The software controller for the bioreactor was designed to be able to control 8 6 
motors at once with the capacity to vary the following parameters: 7 
 1. Linear distance of compression 8 
2. Duration of experiment 9 
3. Frequency of each compressive cycle 10 
4. Run Time Interval (Duration in which cyclic compressions will occur) 11 
5. Wait Time Interval (Duration of rest between each round of compression) 12 
 13 
3.4.3 Compression Regime and Culture Conditions for Simulated IVD-like 14 
Construct 15 
 A rehabilitative regime was chosen for the stimulation of the simulated IVD-like 16 
construct. The rehabilitative regime is based on gradually increasing the forces on the 17 
cells. This would ensure that the cells are conditioned, and produce the appropriate ECM 18 
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to be able to withstand larger forces. The assembly was compressed at 0.25Hz, for 15 1 
minutes a day, for 4 weeks. The compression was increased gradually each week starting 2 
from 5% axial compression followed by 11% for the 2nd week, 18% for the 3rd and finally, 3 
25% for the duration of the 4th week. The simulated IVD-like constructs was cultured in 4 
LG-DMEM supplemented with 15% FBS, 1% penicillin/streptomysin, and 50µg/ml of L-5 
Asc. Medium was changed once a week. 6 
  7 
3.4.4 Investigation of Simulated IVD-like Construct in Dynamic Culture Conditions 8 
a. Alamar Blue Cell-Sheet Viability Assessment 9 
The viability of the cells present within the simulated IVD-like constructs was 10 
determined using the Alamar Blue colorimetric assay (Invitrogen, CA). The cells were 11 
incubated in medium supplemented with 20% (v/v) Alamar Blue dye for 1 h. One 12 
hundred microliters of medium from each sample was read at 570/600nm in a microplate 13 
reader (Sunnyvale, CA). Medium supplemented with 20% Alamar Blue dye was used as 14 
a negative control and the percentage of Alamar Blue dye reduction was calculated 15 
according to the formula stated in Appendix A1. A percentage reduction of Alamar Blue 16 
dye would indicate that the cells assayed are viable. 17 
 18 
b. SDS-PAGE Collagen Type I Quantification and Immunoblotting for Collagen Type II 19 
 The simulated IVD-like constructs were washed twice with 1xPBS after the 20 
Alamar Blue assay and digested with porcine gastric mucosa pepsin (2500 U/mg; Roche 21 
Diagnostics Asia Pacific, Singapore) in a final concentration of 0.25mg/mL. Samples 22 
were incubated at room temperature (RT) for 1h with gentle shaking followed by 23 
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sonication of the solution until all cell fragments have broken up followed by 1hr 1 
incubation at RT. After the incubation step, the samples were neutralized with 0.1 N 2 
NaOH. The samples were analyzed by SDS-PAGE under non-reducing conditions (See et 3 
al 2008). A SDS gel made up of 5% stacking and 7% resolving components were used 4 
(Appendix A4). The gel was run at 50V for 45 minutes and 180V for 95 minutes. 5 
Collagen bands were stained using SilverQuest kit (Invitrogen, Carlsbad, CA) according 6 
to the manufacturer’s protocol (Appendix A3). Densitometric analysis of wet gels was 7 
performed on the GS-800 Calibrated Densitometer (Bio-Rad Laboratories, Hercules, CA) 8 
with the Quantity One v4.5.2 image analysis software (Bio-Rad Laboratories, Hercules, 9 
CA). For western immunoblotting, the sameple were subjected to SDS-PAGE and 10 
transferred to a nitrocellulose membrane. Primary antibodies for collagen type II (mouse 11 
anti-human Col II, MAB8887; Chemicon International, CA, USA) were used at 1:1000 12 
dilutions. The signal was detected with chemiluminescence (AmershamTM ECL Plus 13 
Western Blotting Detection System; GE Healthcare., Buckinghamshire, UK) and 14 
captured with a VersaDoc Imaging System model 5000 (Bio-Rad Laboratories, Hercules, 15 
CA). 16 
  17 
c. Histological Staining (H&E, Alcian Blue, Safranin-O) 18 
The constructs were washed in 1xPBS, fixed in 10% neutral buffered formalin 19 
overnight, dehydrated in a progressively increasing ethanol gradient and then embedded 20 
in paraffin. 5 µm thick sections were cut and collected on silane-coated slides for 21 
immunohistochemical analysis. Before staning, the sections were rehydrated a 22 
progressively decreasing ethanol gradient. The H&E staining technique was performed as 23 
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follows: the samples were staining for 5 minutes with hematoxylin, washed with tap 1 
water and soaked in 0.2% (v/v) ammonium hydroxide for 30 seconds. They were washed 2 
in tap water and soaked in Eosin for 15 seconds. The slides were dehydrated before 3 
application of a coverslip. Alcian Blue staining technique was performed as follows: the 4 
samples where stained for 30 mins with Alcian Blue, washed for 3 min with ddH2O, 5 
stained for 10 min with nuclear fast red and washed for 3 min with ddH2O. The slides 6 
were dehydrated before the application of a coverslip.  The Safranin O/fast green staining 7 
technique was performed as follows: the samples were stained for 3 min with iron 8 
hematoxylin, washed for 3 min with ddH2O, stained for 3 min with fast green. They were 9 
washed in acetic acid for 5 sec and stained for 3 min with Safranin O. The slides were 10 
dehydrated before application of a coverslip.  11 
 12 
d. Immunohistochemical Staining for Collagen Type I and Type II 13 
The constructs were washed in 1xPBS, fixed in 10% neutral buffered formalin 14 
overnight and then embedded in paraffin. 5 µm thick sections were cut and collected on 15 
silane-coated slides for immunohistochemical analysis. 16 
Immunohistochemistry study was carried out as follows: after deparaffinization 17 
and rehydration, endogenous peroxidase in the samples was first blocked with hydrogen 18 
peroxide for 15 min before pepsin treatment for 20 min. Monoclonal antibodies of 19 
collagen type I (Sigma-Aldrich, St Louis, MO) of dilution factor 1:500, collagen type II 20 
(Chemicon Inc., Temecuela, CA) of dilution factor 1:500; and control mouse IgG isotype 21 
(Zymed Laboratories Inc. San Francisco, CA) of dilution factor 1:2500 were applied for 22 
an hour followed by incubation with biotinylated goat anti-mouse (Lab Vision 23 
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Corporation, Fremont, CA) for 30 min. Streptavidin peroxidase was added for 45 min and 1 
3,30-diaminobenzidine was used as a chromogenic agent and counterstaining was done 2 
with hematoxylin. Between each step, the slides were washed with 1xPBS. The slides 3 
were dehydrated before application of a coverslip.  4 
 5 
 6 
e. DNA Quantification 7 
 DNA content measured spectrophotometrically using the Hoechst 33258 method 8 
(Toh et al 2005). The fluorescence measurement of Hoechst 33258 dye was performed 9 
using a fluorescence plate reader (FLUOstar Optima, BMG Labtechnologies, Offenburg, 10 
Germany). Calf thymus DNA was used for construction of the standard curve for DNA 11 
quantification. 12 
 13 
f. RNA Extraction and Real-Time PCR Analysis 14 
 Total RNA was extracted using Trizol® reagent (Invitrogen, Grand Island, NY) 15 
and purified using the RNeasy Mini Kit (Qiagen, Valencia, CA). RNA concentration was 16 
determined using NanoDrop (NanoDrop Technologies, Wilmington, DE) and 17 
complementary DNA synthesis was carried out using 100 ng of total RNA according to 18 
the manufacturer’s protocol for SuperScript II reverse transcriptase with oligo(dT) 19 
primers. Real-Time PCR was done using 2µl of cDNA, 10µl of SYBR Green Master Mix 20 
(Qiagen, Valencia, CA) and the optimized concentration of primers, topped up to 20µl 21 
with nuclease free water. All reactions were performed on the real-time Mx3000P 22 
(Stratagene, CA, USA). The thermal cycling program for all PCRs was the following: 23 
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95ºC for 15 min, followed by 40 cycles of amplifications, consisted of denaturation step 1 
at 94ºC for 15 sec, an annealing step at 55ºC for 30 sec and an extension step at 72ºC for 2 
30 sec. . The genes analysed were Sox9, collagen type I (Col I), collagen type II (Col II),  3 
aggrecan, biglycan and decorin. Primer sequence for GAPDH and Collagen Type I (Col I) 4 
were previously described (Fan et al 2008). Remaining primers were designed using the 5 
Oligo 6.0 program and are listed in Table 4.3.5f. The level of expression of the target 6 
gene, normalized to GAPDH, was then calculated using the 2∆Ct formula (Livak, & 7 
Schmittgen 2001) with reference to the respective control groups which are set to 1. 8 
 9 
3.4.5 Statistical Analysis 10 
 All data is expressed as mean ± standard deviation (SD). All statistical analysis 11 
was performed by pair-wise comparison of experimental categories using two-tailed, 12 
unpaired student t-test. A p-value <0.05 was considered significant. Statistical analysis 13 















4.1 Phase I – Fabrication and Characterization of BMSC Cell-Sheet 1 
4.1.1 Investigation on the Suitability of DexS to Aid BMSC Cell-Sheet Formation 2 
a. SDS-PAGE Collagen Type I Quantification 3 
 From the SDS-PAGE results, it was shown that MMC using inert, negatively 4 
charged dextran sulphate for a period of 2 days was able to greatly enhance the collagen 5 
type I deposition on the cell layer (Fig 4.1.1a top). However, when another experiment 6 
was performed to determine the suitability of using MMC for long term culture on 7 
BMSCs, the SDS-PAGE gel results did not show an increase in collagen type I 8 
deposition for treatment C (twice DexS treated) over treatment A (once DexS treated) or 9 
B. In fact, treatment B (no DexS treatment) had the densest band, indicating more 10 
collagen type I deposition on the cell layer.  11 
 12 
Fig 4.1.1a: (top) MMC treatment to aid Collagen Type I deposition 13 
(bottom) Collagen type I deposition does not increase after MMC treatment 14 
1          2          3 
1: L-Asc 
2: L-Asc + DexS 
3: Collagen Type I standard 
1         2          3       4 
1: Treatment A 
2: Treatment B 
3: Treatment C 
4: Collagen Type I standard 
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b. Alamar Blue Cell-Sheet Viability Assessment between DexS and non DexS treated 1 
Cell-Sheets 2 
From the data obtained from the Alamar Blue assay (Fig 4.1.1b), the cells in the 3 
cell-sheet were shown to remain viable during the 3 weeks of culture. There was no 4 
significant difference between the results when the cells were initially seeded, but the 5 
cell-sheets supplemented with L-Asc and DexS showed a significant decrease in the 6 

















Asc Asc + DS
 8 
Fig 4.1.1b: Figure showing a significant decrease of cell-sheet viability between cultures 9 
supplemented with L-Asc and DexS (last 2 days) when compared to cultures with only L-10 
Asc throughout 11 
 12 
4.1.2 Technique to Accurately Quantify Collagen Content in Hyperconfluent 13 
Culture 14 
a. Collagen Structure Unaffected by Sonication Treatment 15 
 Pepsin treatment of the cell layer destroys non collagenous components while 16 





entirely digested without the aid of sonication, therefore a comparison was done to prove 1 
that sonication did not affect the collagen structure as shown in Fig 4.1.2a. The Alamar 2 
Blue analysis showed no significant difference in cell numbers between samples that 3 
were not going to be sonicated and the samples that were going to be sonicated (Fig 4 
4.1.2a). Densitometry showed no significant difference in collagen deposition between 5 
the sonicated sample and the un-sonicated sample of both BMSCs and fibroblasts (Fig 6 
4.1.2a(b, c)).  7 
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 1 
Fig 4.1.2a: (a) Alamar Blue analysis of sample wells shows no significant difference in 2 
cell numbers between sonicated and unsonicated samples of both BMSCs and fibroblasts 3 
at confluence; (b) Sonication does not affect collagen structure in both rabbit derived 4 
BMSCs and fibroblasts. Silver stained SDS-PAGE of peptic collagen extracts from the 5 
cell layer at 100% confluence. No difference observed in intensity and location of bands 6 
between sonicated and un-sonicated samples. MW STD, molecular weight ladder; 7 
BMSCs, bone marrow stromal cells; S, sonicated samples; (c) Graph showing the 8 
collagen quantified with and without sonication for both BMSCs and fibroblasts. Cells 9 
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were grown till confluence for this study. The results obtained are not statistically 1 
different *, p>0.05 2 
 3 
b. Collagen Quantification in Hyperconfluent Culture Aided by Sonication 4 
 Although pepsin is able to destroy non collagenous components in early stages of 5 
culture, it is unable to efficiently destroy all non collagenous components in 6 
hyperconfluent cell cultures. But total destruction of all non collagenous components was 7 
achieved with the aid of a sonication step during the digestion process. The Alamar Blue 8 
analysis showed that there was no significant difference in cell numbers between the 9 
samples that were going to be sonicated and samples that were not going to be sonicated 10 
(Fig 4.1.2b(a)). Densitometry showed a significant difference in the density of collagen 11 
bands of samples obtained by culturing the cells for another 2 weeks after 100% 12 
confluence (Fig 4.1.2b(b)). The bands that have a significant difference are the collagen I 13 
crosslinking bands, β11, β12, and collagen I main chain bands, α1 and α2. This can be seen 14 
from the results of both the BMSC and fibroblasts cells. Results of the densitometric 15 
analysis of the gel bands show that the increase in collagen detected is stastically 16 
significant (Fig 4.1.2b(c)).  17 
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 1 
Fig 5.1.2b: (a) Alamar Blue analysis of sample wells shows no significant difference in 2 
cell numbers between sonicated and unsonicated samples of both BMSCs and fibroblasts 3 
at 2 weeks post confluence. *, p>0.05; (b) Sonication releases collagen that is trapped 4 
within cell layer fragments even after peptic digestion in both rabbit derived BMSCs and 5 
fibroblasts. Silver stained SDS-PAGE of peptic collagen extracts from the cell layer 2 6 
weeks after 100% confluence. An obvious difference can be observed in intensity 7 
between sonicated and un-sonicated samples. Collagen fibrils are completely released by 8 
sonication. MW STD, molecular weight ladder; BMSCs, bone marrow stromal cells; S, 9 
sonicated samples; (c) Graph showing the increase in collagen quantified by sonication 10 
with both BMSCs and fibroblasts. Cells were grown till 2 weeks post confluence for this 11 
study. The results obtained are statistically different. *, p<0.05. 12 
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4.1.3 Investigation of BMSC Cell-Sheet Growth Post-Confluence 1 
a. SDS-PAGE Collagen Type I Quantification  2 
 The results were obtained after densitometric analysis of the SDS-PAGE bands, 3 
followed by normalizing the data with the DNA content of the cell-sheets. The results 4 
show a steady increase of collagen type I deposition after each week. 5 
 6 
 











Fig 4.1.3a: Results of collagen type I deposition at weekly time points 8 
 9 
b. Immunofluorescence for Cell-Sheet Thickness Assessment using Confocal Microscopy 10 
 It was observed that the hyperconfluent cell-sheet grew progressively thicker from 11 
36.7 ± 2.1µm at week 0 to 78.5 ± 4.5 µm at week 3 with significant changes occurring 12 
between the 1st 2 weeks. 13 
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 1 
Fig 4.1.3b: Confocal microscopy results for cell-sheet thickness at weekly time points 2 
 3 
c. SEM Analysis 4 
 The morphology of 2 week old cell-sheets was observed by phase contrast 5 
microscopy and SEM images. The results show that cell conformation and, indeed, 6 
individual cells cannot be distinguished by phase contrast and scanning electron 7 





















Fig 4.1.3c: Phase contrast (a, b) and SEM (c, d) images of 2 week old cell-sheets showing 2 
very dense mesh-like structures. (a) scale bars = 1mm; (b) scale bars = 200µm; (c) scale 3 
bars = 10µm; (d) scale bars = 5µm. 4 
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4.2 Phase II – Characterization of BMSC Cell-Sheet Multipotentiality and 1 
Comparison between Conventional BMSC Differentiation Protocols 2 
 3 
4.2.1 Assessment of Adipogenic Differentiation of BMSC Cell-Sheets 4 
a. Histochemical staining of Adipocytes 5 
 After 3 weeks of adipogenic differentiation, Oil Red O staining showed that both 6 
CI and CSI cultures had visible cytoplasmic lipid droplets formations within the cells 7 
(Fig 4.2.1a). Cytoplasmic lipid droplet formation was observed as early as the end of the 8 
1st cycle of induction. After each cycle, the number and size of lipid droplets increased. 9 
 10 
Fig 4.2.1a: Oil Red-O with hematoxylin counterstain of CI and CSI cultures compared to 11 
their NI cultures. CI and CSI cultures had large cytoplasmic lipid droplets (b, d) but the 12 




b. Gene Expression of Adipogenic Differentiation Cultures 1 
 In both CI and CSI cultures, when compared to their respective NI cultures, 2 
mRNA expression levels of PPARγ2 and aP2 were significantly upregulated while leptin 3 
was significantly downregulated. The mRNA expression level of PPARγ2 and aP2 for CI 4 
cultures compared to the respective NI cultures resulted in a 3.1 ± 1.4 fold and 118 ± 63 5 
fold increase respectively (Fig 4.2.1b(a)), while the CSI cultures compared to its 6 
respective NI culture had a 3.1 ± 0.2 and 65.6 ± 4.5 fold increase (Fig 4.2.1b(b)). Leptin 7 
mRNA expression levels on the other hand was markedly downregulated in both CI and 8 
CSI cultures, at 0.004 and 0.08 fold respectively. Comparing the mRNA expression 9 
levels between CI and CSI cultures, CSI cultures had a slight increase in PPARγ2 and 10 
aP2 expression of 1.27 ± 0.07 and 1.24 ± 0.08 fold respectively, but leptin mRNA 11 
expression was significantly higher at 10.7 ± 2.2 fold (Fig 4.2.1b(c)). 12 
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 1 
Fig 4.2.1b: Real Time RT-PCR of adipogenic genes (PPARγ2, aP2 and leptin) results 2 
compared between CI and CSI with their respective NI cultures (a, b) followed by a 3 
comparision of the gene expression between CI and CSI cultures (c). The level of 4 
expression of each target gene was normalized to GAPDH and calculated using the 2∆Ct 5 
formula with reference to the respective control groups, which are set to 1. For (a, b), 6 
PPARγ2 and aP2 was significantly upregulated while leptin was significantly 7 
downregulated. *p<0.05 8 
 9 
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4.2.2 Assessment of Chondrogenic Differentiation of BMSC Cell-Sheets 1 
a. Histological and Immunohistochemical assessment of pellet cultures 2 
After 3 weeks of chondrogenic differentiation, Safranin-O staining showed that 3 
both CSI and CI micromass cultures had rich amounts of glycosaminoglycans, and 4 
immunohistochemical staining for collagen type I and II showed that both cultures had a 5 
small amount of collagen type I matrix and a large content of collagen type II matrix (Fig 6 
4.2.2a) when compared to the respective NI cultures which had predominantly collagen 7 
type I matrix. However, collagen type II matrix was barely detectable.  8 
 9 
Fig 4.2.2a: Safranin-O with fast green counter stain of CI and CSI micromass pellets (a, 10 
d). Immunohistochemical staining of Col I (b, e) and Col II (c, f) showed that both 11 
induced micromass pellet cultures had strong Col II staining and very weak Col I staining. 12 





b. Gene Expression of Chondrogenic Differentiation Cultures 1 
In both CSI and CI micromass cultures, when compared to their respective NI 2 
cultures, mRNA expression of Sox9, aggrecan and collagen type II were significantly 3 
upregulated. The mRNA expression level of Sox9, aggrecan and Col I for CI micromass 4 
cultures compared to the respective NI cultures resulted in a 18 ± 2.7, 215 ± 69 and 17.7 5 
± 3.4 fold increase respectively (Fig 4.2.2b(a)), while the CSI cultures compared to its 6 
respective NI culture had a 24.5 ± 9.2, 102 ± 31 and 4.26 ± 0.65 fold increase (Fig 7 
4.2.2b(b)). On the other hand, collagen type II mRNA expression levels could not be 8 
quantified as both NI micromass cultures of CI and CSI did not have a measurable Ct 9 
value. The EtBr gel results distinctly showed that for both NI cultures, no collagen type II 10 
product was formed, while a thick band was found for both CI and CSI cultures (Fig 11 
4.2.2b(c)). Comparing the mRNA expression levels between CI and CSI micromass 12 
cultures, CSI cultures had increases in all 4 gene expression of 5.4 ± 2.0, 18.3 ± 5.5, 15.6 13 
± 7.4 and 2.56 ± 0.4 fold for Sox9, aggrecan, collagen type II and collagen type I 14 




Fig 4.2.2b: Real Time RT-PCR of chondrogenic genes (Sox9, Aggrecan, Col I and Col II) 2 
results compared between CI and CSI with their respective NI cultures (a, b). A 3 
comparison of gene expression was done between CI and CSI cultures (c). The level of 4 
expression of each target gene was normalized to GAPDH and calculated using the 2∆Ct 5 
formula with reference to the respective control groups, which are set to 1. Ethidium 6 
bromine gel of Col II products (d) showed close to no expression of Col II products for 7 




4.2.3 Assessment of Osteogenic Differentiation of BMSC Cell-Sheets 1 
a. Histochemical staining of Osteocytes 2 
After 4 weeks of osteogenic differentiation, Alizarin Red S staining showed that 3 
both CI and CSI cultures had calcium deposits when cultured in osteogenic induction 4 
media, whereas no calcium deposits were found in the NI cultures (Fig 4.2.3a). 5 
 6 
Fig 4.2.3a: Alizarin Red staining of CI and CSI cultures compared to their NI cultures. 7 
Both NI cultures did not have any stain (a, c) and the positive staining of CSI cultures (d) 8 
is visibly much more than in CI cultures (b). Scale bars = 500µm. 9 
 10 
b. Gene Expression of Osteogenic Differentiation Cultures 11 
In osteogenic medium, mRNA levels of Runx2, Collagen type I (Col I), 12 
Osteopontin (OPN) and Osteonectin (ON) from CSI and CI cultures were upregulated as 13 
compared to the NI cultures. At the end of the 4 week induction period, the mRNA level 14 
of Runx2 in the CI cultures was 5.6 ± 1.3 fold higher when compared to the respective NI 15 
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culture. Col I was 4.7 ± 0.1 fold higher while OPN and ON was upregulated by a factor 1 
of 1.56 ± 0.5 and 2.55 ± 0.25 respectively. The mRNA level of Runx2 in the CSI cultures 2 
was 3.3 ± 0.8 fold higher when compared to the respective NI culture. Col I was 4.27 ± 3 
1.44 fold higher while OPN, and ON was both upregulated by a factor of 3.5 ± 0.8 and ± 4 
0.7 respectively.  CI cultures had a higher upregulation of Runx2 and a lower 5 
upregulation of the OPN gene, while CSI cultures had a lower upregulation of Runx2 and 6 
higher upregulation of the OPN gene. When the mRNA expression levels of these genes 7 
were compared between CI and CSI cultures, it was found that CSI cultures expressed 8 
significantly more osteogenic specific genes than CI cultures (Fig 4.2.3b). 9 
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 1 
Fig 4.2.3b: Real Time RT-PCR of osteogenic genes (Runx2, Col I, ON and OPN) results 2 
compared between CI and CSI with their respective NI cultures (a, b), followed by a 3 
comparision of the gene expression between CI and CSI cultures (c). The level of 4 
expression of each target gene was normalized to GAPDH and calculated using the 2∆Ct 5 
formula with reference to the respective control groups, which are set to 1. In all graphs, 6 
all 4 genes tested were significantly upregulated. *p<0.05 7 
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4.3 Phase III – Fabrication and Verification of a Simulated IVD-like Assembly 1 
4.3.1 Characterization of Silicone Nucleus Pulposus 2 
a. Calculation of Swelling Pressure (Hoop Stress) of Silicone NP 3 
 The swelling pressure of the silicone NP was calculated from 16% to 30% axial 4 
compression to determine the optimal axial compression that would give a swelling 5 
pressure of 0.05MPa. It was determined that a 25% axial compression gave an average 6 
swelling pressure of 0.0505 ± 0.0023 MPa. (Detailed calculations are shown in Appendix 7 
A6).  8 
 9 
b. Effects of Ethylene Oxide Sterilization on the Mechanical Properties of the Silicone NP 10 
 Despite using the same protocol to fabricate 6 batches of silicone cylinders, the 11 
average Young’s Modulus at 25% compression of batches A to F varies from as low as 12 
1.04MPa to a high of 1.32MPa (details in Appendix A7). However, the Young’s Modulus 13 
at 25% compression after ethylene oxide sterilization showed no significant change 14 
(p>0.05) from the pre-sterilized values for all 6 batches (Fig 4.3.1b). 15 
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 1 
Fig 4.3.1b: No significant difference of Young’s Modulus at 25% axial compression 2 
within each Silicone NP batch before and after sterilization. *p>0.05 3 
 4 
c. Effects of Cyclic Loading on the Mechanical Properties of the Silicone Nucleus 5 
Pulposus 6 
 The Young’s Modulus of the silicone discs from both batch B and batch D (Fig 7 
4.3.1c) did not differ significantly after each day of the cyclic loading tests when tested 8 
with a 25% axial compression. The Young’s Modulus of the discs was also not 9 
significantly different before and after the entire 3 day experiment (details in Appendix 10 
A8). 11 
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  2 
Fig 4.3.1c: Experiment done to show that the Young’s Modulus of the silicone discs from 3 
batch B (top) and batch D (bottom) do not change significantly after cyclic loading. 4 
*p>0.05 5 
 6 
d. Standardizing of Hoop Strain between Batches of Silicone Nucleus Pulposus 7 
 The hoop strain of Batch A was calculated to be 14.7±0.4% at a 25% axial 8 
compression. Batches B and D required a 23% axial compression to attain a 14.7±0.5% 9 
Young's modulus of silicone discs from Batch B 
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and 14.6±0.4% hoop strain respectively, which batches C, E and F required a 24% axial 1 
compression to attain a 15.1±0.3%, 15.0±0.6% and 15.0±0.8% hoop strain respectively 2 
(details of results in Appendix A9). The hoop strain of batches B to F was not 3 
significantly different from that of batch A. 4 
 5 
Fig 4.3.1d: Hoop strain of batches A to F. Batch B and D require 23% axial compression 6 
while batch C, E and F require 24% axial compression to attain a similar hoop strain 7 
profile to batch A. * p>0.05 when tested against batch A. 8 
 9 
4.3.2 Investigation of Simulated IVD-like Assembly in Static Culture Conditions 10 
a.  Alamar Blue Simulated IVD-like Assembly Viability Assessment 11 
From the data obtained from the Alamar Blue assay (Fig 4.3.2a), the cells in the 12 
simulated IVD-like construct were shown to remain viable during the 4 weeks of static 13 
culture. 14 
Standardizing Hoop Strain between                                      
























Fig 4.3.2a: Cells within the simulated IVD-like construct remain viable  2 
after 4 weeks of static culture 3 
 4 
b. Histological Staining (H&E, Alcian Blue, Safranin-O) 5 
 After 4 weeks of static culture of the simulated IVD-like assembly, H&E staining 6 
showed that the cell-sheets adhered to the scaffolds (Fig 4.3.2b(a,d)). Alcian Blue 7 
staining was positive but Safranin-O was negative (Fig 4.3.2b(b,c,e,f). The results show 8 




















Fig 4.3.2b: H&E (a,d), Alcian blue (b,e) and Safranin-O (c,f) staining of simulated IVD-2 
like assembly after 4 weeks of static culture. Scale bars = 500µm (a,b,c) and 200µm (d,e,f) 3 
 4 
c. Immunohistochemical Staining for Collagen Type I and Type II 5 
 After 4 weeks of static culture of the simulated IVD-like assembly, 6 
immunohistochemical staining of collagen type I and collagen type II indicate that both 7 
types of collagen are found within the ECM (Fig 4.3.2c). There was no specific 8 




Fig 4.3.2c: Immunohistochemical staining of the simulated IVD-like assembly after 4 2 
weeks static culture. (a,d): IgG control; (b,e): Col I; (c,f): Col II. Scale bars = 200µm 3 
(a,b,c) and 100µm (d,e,f). 4 
 5 
 6 
d. Analysis of ECM for Collagen Type I Composition 7 
SDS-PAGE was used to analyze the composition of the ECM of the cell-sheets 8 
before transplantation and after 4 weeks of static culture. It was shown that collagen type 9 
I content decreased over the 4 weeks of static culture (Fig 4.3.2d).  10 
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 1 
Fig 4.3.2d: SDS-PAGE to determine ECM composition of 2 week old cell-sheets and 4 2 
week static culture of simulated IVD-like assembly. 4 week static cultures showed a 3 




4.4 Phase IV – Bioreactor Studies of Simulated IVD-like Assembly  1 
4.4.1 Investigation of Simulated IVD-like Construct in Dynamic Culture Conditions 2 
a. Alamar Blue Simulated IVD-like Assembly Viability Assessment (Static vs Dynamic) 3 
 The results of the Alamar Blue assay show that the cells cultured in static and 4 
dynamic conditions remain viable over the 4 week period (Fig 4.4.1a). However, after 5 
week 2, the metabolic rate of the cells cultured under dynamic conditions begins to drop, 6 
and at week 4, the cells within the dynamic culture have a distinctly lower metabolic rate 7 
than the static control cultures. 8 
 9 
Fig 4.4.1a: Cells of both the static and dynamic cultures remain viable and metabolically 10 
active over 4 weeks. However, the metabolic rate of the cells within the dynamic cultures 11 
begins to decrease after the 2nd week. 12 
 13 
b. SDS-PAGE Collagen Type I and Immunoblot for Collagen Type II  14 
 The results of the SDS-PAGE indicate a decrease in the amount of collagen type I 15 
within the ECM of the assemblies within the dynamic culture at Week 2 and Week 4. 16 
When compared to the static control, the composition of collagen type I in the ECM was 17 
also reduced. For collagen type II immunoblot, it is shown that the deposition of collagen 18 
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type II occurs in both the static culture and dynamic culture after 4 weeks. However, at 2 1 
weeks, deposition of collagen type II was barely detected. 2 
 3 
Fig 4.4.1b: SDS-PAGE collagen type I and type II between 4 weeks static culture and 2 4 
weeks/4 weeks dynamic culture. Collagen type I deposition decreased over the 4 week 5 
dynamic culture period. Collagen type II was detected in both 4 week static and 4 week 6 
dynamic culture 7 
 8 
c. Histological Staining (H&E, Alcian Blue, Safranin-O) 9 
 After 2 weeks and 4 weeks of dynamic culture, the simulated IVD-like assembly 10 
was sacrificed for histological analysis. H&E staining showed that the cell-sheets adhered 11 
well to the scaffolds (Fig 4.4.1c(a,d)). Both Alcian Blue and Safranin-O staining was 12 
positive at both 2 weeks and 4 weeks of dynamic culture (Fig 4.4.1c(b,c,e,f). The results 13 





Fig 4.4.1c: H&E (a,d), Alcian blue (b,e) and Safranin-O (c,f) staining of simulated IVD-2 
like assembly after 2 weeks and 4 weeks of dynamic culture. Scale bars = 500µm (a,b,c) 3 
and 200µm (d,e,f) 4 
 5 
d. Immunohistochemical Staining for Collagen Type I and Type II 6 
After 2 weeks and 4 weeks of dynamic culture, the simulated IVD-like assembly 7 
was sacrificed for immunohistochemical staining analysis. It is concluded that both 8 













Fig 4.4.1d: Immunohistochemical staining of the simulated IVD-like assembly after 2 2 
weeks (top) and 4 weeks (bottom) of dynamic culture. (a,d): IgG control; (b,e): Col I; 3 
(c,f): Col II. Scale bars = 200µm (a,b,c) and 100µm (d,e,f). 4 
 5 
e. Real-Time PCR Analysis between Static and Dynamic Cultures of the Simulated IVD-6 
like Assembly 7 
After 4 weeks of dynamic culture in the bioreactor, the mRNA expression levels 8 
of Sox9, collagen type I (Col I), aggrecan (Aggr) and decorin (Dec) were upregulated 9 
when compared to the mRNA expression levels of the IVD-like assemblies in 4 weeks of 10 












2.68 ± 0.7 fold higher when compared to the 4 week static cultures. Col I mRNA 1 
expression level was 2.00 ± 0.4 fold higher while aggrecan and decorin was upregulated 2 
by a factor of 6.54 ± 1.2 and 3.96 ± 1.2 respectively. The only gene that was significantly 3 
upregulated by the 2 week dynamic culture period when compared to the 4 week static 4 
culture was collagen type II (Col II). The mRNA expression level of collagen type II was 5 
upregulated by a factor of 4.10 ± 0.9 at the 2 week dynamic culture time point and further 6 
upregulated to 8.55 ± 2.6 folds by the 4 week dynamic culture period. However, the gene 7 
expression of biglycan did not show can significant upregulation even after 4 weeks of 8 
dynamic culture. 9 
 10 
Fig 4.4.1e: Real Time RT-PCR results of common IVD genes (Sox9, Col I, Col II, Aggr, Bi, Dec) 11 
compared between 2 week and 4 week dynamic cultures against 4 week static cultures. The level 12 
of expression of each target gene was normalized to GAPDH and calculated using the 2∆Ct 13 
formula with reference to the control group, which are set to 1. At week 2, only Col II was 14 
upregulated, but at week 4, all the genes but biglycan were upregulated and Col II was 15 













5.1 Phase I – Fabrication and Characterization of BMSC Cell-Sheet 1 
Fabrication of a stable engineered tissue depends largely on the formation of the 2 
ECM. An integral part of the ECM is made up of collagen. Research has shown that L-3 
Asc accelerated procollagen processing to collagen and therefore enhanced the rate of 4 
collagen synthesis over long term culture (Hata, & Senoo 1989). In a more recent in vitro 5 
study, it was shown that collagen deposition was enhanced by using EVE on top of 6 
adding L-Asc (Lareu et al 2007). EVE was achieved by adding DexS, an inert 7 
macromolecular crowder to the culture media. The study showed that the enhanced ECM 8 
formation was also due to an acceleration of procollagen conversion. The experiment 9 
using L-Asc together with EVE to improve collagen deposition was done on terminally 10 
differentiated cells in short term in vitro culture. With an increasing interest in formation 11 
of a robust BMSC cell-sheet, it is important that we characterize the effects of L-Asc 12 
together with EVE in long term cultures on BMSCs and using the better technique to 13 
fabricate and characterize the BMSC cell-sheet process. Hence this study was conducted 14 
with these aims in mind. 15 
In order to characterize the effects of L-Asc together with EVE on BMSCs in long 16 
term culture, we followed the procedures in delivering a pulse of EVE for 2 days just 17 
before harvesting for assessment (Lareu et al 2007). Alamar blue cell viability assay and 18 
SDS-PAGE quantification of collagen deposition was evaluated. The L-Asc together with 19 
EVE treated cultures were compared to the ones with only L-Asc treatment. 20 
The experimental results show that EVE was able to improve the efficiency of 21 
collagen type I deposition on the BMSC cell layer at confluence (Fig 4.1.1a (top)). 22 
However, when the experiment was extended in an attempt to use EVE in pulses 23 
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(Treatment C) to further improve the collagen type I deposition, the results was not 1 
comparable to that of the wells of only L-Asc treatment (Treatment B). Moreover, the 2 
results from the Alamar Blue assay also showed that cultures that are treated with DexS 3 
have a significantly lower viability when compared to the non DexS treated cultures (Fig 4 
4.1.1b). It was concluded that the BMSCs treated with EVE had an improved efficiency 5 
of collagen deposition, but the technique is ineffective in pulses. Since the viability of the 6 
cells was significantly reduced after treatment with EVE, it is not a feasible technique to 7 
aid in improving the existing fabrication method of a cell-sheet. 8 
The technique of using pepsin digestion for assessment of collagen content in 9 
short term cultures are accurate. However, this technique is not robust enough to digest 10 
hyperconfluent cell layers from long term cultures, as shown in Fig 4.1.2b. Therefore, to 11 
accurately quantify the collagen content within the hyperconfluent cell layers, we have 12 
shown in our results, (Fig 4.1.2a) that sonication does not affect the structure and 13 
concentration of collagen from short term subconfluent cell cultures, and also, 14 
successfully shown that sonication of the fragments left behind after peptic digestion aids 15 
to breakdown the cell sheet fragments. The breakdown of the indigestible cell sheet 16 
fragments release the collagen fibrils that were trapped within the fragments, as shown in 17 
our results. (Fig 4.1.2b) The maintenance of collagen without obvious denaturation and 18 
peptic cleavage, and the increase in yield of insoluble collagen content is consistent with 19 
previous results (Takahashi et al 1991), thus showing that we have improved upon 20 
current methods of collagen quantification for assessment of tissue engineered cell sheets. 21 
For the 2nd part of Phase 1, we wanted to characterize the BMSC cell-sheet 22 
growth profile at weekly time points, as there has not been any such study performed 23 
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previously. Ouyang et al. 2006 published data using 2-3 week old BMSC cell-sheets to 1 
revitalize grafts of bone and tendon, Wang et al. 2008 used 1 week old BMSC cell-sheet 2 
fragments to improve cardiac functions after myocardial infarct and Akahane et al. 2008 3 
used the cell-sheets at confluence for bone formation at an ectopic site. However, they 4 
did not report any work done to characterize the growth of the BMSC cell-sheets during 5 
the fabrication period, hence was our motivation for these series of experiments.  6 
We have successfully cultured rabbit BMSCs to hyperconfluent cell-sheets using 7 
L-Asc as the only additive to the culture medium. The cells in the cell-sheet were shown 8 
to remain viable throughout the 3-week culture period and no significant change in cell 9 
number was observed. It was also observed that the cells continue to produce collagen 10 
throughout the period of study and the cell-sheet grew progressively thicker, ie from an 11 
initial 36.7 ± 2.1µm at week 0 to 78.5 ± 4.5 µm at week three. The morphology of the 12 
cell-sheet was observed through phase contrast microscopy and SEM images (Fig 4.1.3c), 13 
and it was found that the cells were arranged randomly in a dense mesh-like tissue. 14 
When we compared the BMSC cell-sheet fabrication technique presented by 15 
Wang et al. 2008, we found out that they did not use L-Asc during the cell-sheet 16 
fabrication period. Our rational of using L-Asc was to improve ECM deposition using the 17 
fabrication period; however, their group had a higher seeding density of 5 x 104 cells/cm2 18 
as compared to ours which was seeded at 3 x 104 cells/cm2. The 67% increase in the 19 
number of cells seeded might have made up for the lack of use of L-Asc for the cell-sheet 20 
fabrication to obtain an ECM structure robust enough for transplantation. Conversely, 21 
Akahane et al. 2008 had a very low seeding density of 1 x 104 cells/cm2, and their group 22 
had used L-Asc at a concentration of 82µg/ml immediately after seeding the cells. 23 
 108 
Despite using L-Asc, it still took approximately 14 days to reach confluence. When 1 
compared with our fabrication protocol, the seeding density of 3 x 104 cells/cm2 was able 2 
to reach confluence in 1-2 days without the use of L-Asc. 3 
When compared to the other reports using cell-sheets, we’ve managed to fabricate 4 
a cell-sheet using a lower cell seeding density and yet form a robust ECM structure 5 
within the shortest time. 6 
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5.2 Phase II – Characterization of BMSC Cell-Sheet Multipotentiality and 1 
Comparison between Conventional BMSC Differentiation Protocols 2 
Due to their multilineage potential, BMSCs are widely used in the field of tissue 3 
engineering (Dezawa 2008,Lin et al 2008,Wang et al 2005,Ge et al 2005,Liu et al 4 
2008,Altman et al 2002). Primary cultures of BMSCs grow in dense colonies. To obtain 5 
sufficient cell numbers to culture BMSC cell-sheets, a commonly used method is to use 6 
trypsin to disrupt the ECM and cell-cell adhesion proteins so that the cells can be 7 
suspended and re-plated with more space to proliferate. When sufficient cell numbers are 8 
obtained, the cells are trypsinized and seeded to form cell-sheets. Trypsin is less of a 9 
concern during cell-sheet formation stage because the cells can recover from the damage 10 
caused by the trypsin treatment during the period of cell-sheet formation. However, once 11 
the cell-sheet is formed, use of the trypsinization method should be avoided. A preferred 12 
method is the use of thermosensitive polymers to harvest the cell-sheets for 13 
transplantation.  This method also alleviates the problem associated with loss of cell 14 
numbers due to single cell suspension seeding before transplantation.  15 
The use of cell-sheets have generally been limited to terminally differentiated 16 
cells for various tissue engineering approaches to aid in the repair and regeneration of a 17 
specific tissue (Shimizu et al 2003,Michel et al 1999). There have been reports claiming 18 
the use of BMSC cell-sheets for cartilage (Zhang et al 2009) and bone tissue engineering 19 
(Zhou et al 2010), however, the reported method of fabrication of the cell-sheets involved 20 
differentiating the BMSCs and culturing them till cell-sheets form. These methods are 21 
similar to using terminally differentiated cells to fabricate cell-sheets. There have also 22 
been studies done using BMSCs cultured to form cell-sheets that are used for bone and 23 
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tendon tissue engineering (Ouyang et al 2006) and recently, for improving cardiac 1 
function after an infarction (Wang et al 2008). These reported methods involve culturing 2 
the BMSCs till they form cell-sheets before they are differentiated to osteocytes, or 3 
directly injected into the infarct heart. With the growing interest in the use of BMSC cell-4 
sheets for therapeutic applications, it is essential to characterize the multilineage 5 
differentiation capability of BMSC that are cultured into hyperconfluent cell-sheets. 6 
Hence this study was performed with such an aim in mind.  7 
In order to characterize the retention capacity of the multilineage property of the 8 
BMSC after being cultured to a hyperconfluent cell-sheet, we followed well established 9 
standard procedures and differentiated the BMSC in the cell-sheets into osteogenic, 10 
chondrogenic and adipogenic lineages (Pittenger et al 1999,Zou et al 2008,Nöth et al 11 
2002). mRNA levels of key transcription factors and lineage specific proteins explicit for 12 
all three mesenchymal lineages under osteogenic, adipogenic, and chondrogenic 13 
conditions were evaluated. Their expression levels were compared with conventional 14 
differentiated cultures. Immunohistochemical and histochemical staining of cell layers 15 
and sections were also performed to demonstrate the presence of critical morphological 16 
structures and protein deposition of each mesenchymal lineage.  17 
Differentiation of BMSCs into osteogenic, adipogenic and chondrogenic lineages 18 
required a specific cocktail of supplements to be added to the basal medium. Osteogenic 19 
differentiation medium has been well documented. Supplements of dexamathasone, L-20 
Ascorbic acid and β-glycerolphosphate are essential to direct uncommitted BMSCs down 21 
the osteogenic lineage (Jaiswal et al 1997). Studies have shown that BMSCs cultured in 22 
the presence of serum and L-Ascorbic acid spontaneously differentiate into osteoblasts 23 
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(Franceschi et al 1994,Matsumoto et al 1991), and BMPs are able to stimulate the 1 
differentiation process (Yamaguchi et al 1996).  2 
The results show that this combination of these 4 supplements was able to 3 
upregulate osteogenic specific genes, ie. Runx2 (a key transcription factor associated 4 
with osteoblast differentiation), ON (a key calcium binding glycoprotein), OPN (an 5 
anchor of osteoclasts to bone) and Col I (Reinholt et al 1990) were all upregulated. This 6 
is in agreement with previous publications (Zou et al 2008,Guillot et al 2008) that had 7 
indicated the upregulation of these genes. The osteogenic gene expression (ie. early phase: 8 
Runx2 and ON; late phase: Col I and OPN) of CI and CSI cultures showed increases with 9 
respect to their respective NI cultures. These results also indicate that there were more 10 
cells in the CSI culture that expressed late stage osteogenic genes as compared to the CI 11 
cultures. Between the CI and CSI cultures, the mRNA expression levels of all 4 genes in 12 
the CSI cultures were significantly higher when compared to that of the CI cultures. The 13 
difference in Alizarin Red S staining showed that CSI cultures deposited significantly 14 
more calcium on the cell layer. However, CI and CSI cultures had vastly different cell 15 
numbers, we were not able to normalize the calcium deposited to make a comparison 16 
between the CI and CSI cultures. Nevertheless, the cell-sheet cultures retained their 17 
osteogenic differentiative capacity despite being cultured beyond 2 weeks post 18 
confluence.  19 
Adipogenic differentiation induction medium which contains isobutyl-20 
methylxanthine, insulin, dexamathasone, and indomethacin has the ability to direct 21 
BMSCs towards the adipogenic lineage. This has been well documented (Nöth et al 22 
2002). Recently, adipogenic induction has been shown to be effective when done in 23 
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phases, ie alternating between induction and maintenance medium (Janderová et al 1 
2003,Nakamura et al 2003). Our results showed that for both CI and CSI cultures, mRNA 2 
expression levels for PPARγ2 - which is upregulated early in adipocyte differentiation 3 
(Chawla et al 1994,Tontonoz et al 1994) and aP2 - a late adipogenic marker (Fink et al 4 
2004), were both significantly upregulated when compared to the respective controls. The 5 
data obtained was substantiated by the positive staining of the cytoplasmic lipid droplets 6 
using Oil Red O. The downregulation of leptin mRNA in both adipogenic induced 7 
cultures were also in agreement with previous reports which showed that leptin enhances 8 
osteogenesis and inhibits adipogenesis (Thomas et al 1999,Yang et al 2008,Chang et al 9 
2006). When mRNA expression levels of the two adipogenic induced cultures were 10 
compared, there was barely any significant difference observed between both sets of data. 11 
It can be hypothesized that although the ECM found within the cell-sheet did not provide 12 
additional cues to enhance differentiation of BMSC into adipocytes, it was able to 13 
preserve the adipogenic potential of the BMSC. This hypothesis is in agreement with a 14 
previous study which showed that adipogenic potential of late passage BMSCs was 15 
retained when cultured on denatured collagen type I matrix (Mauney et al 2005). 16 
However, more extensive studies are required to determine the possible biological cues 17 
found within the secreted cell-sheet ECM that was able to aid the retention of BMSC 18 
adipogenic potential. 19 
Chondrogenic differentiation involves culturing MSCs in micromass cultures with 20 
TGF-β3 to induce differentiation towards the chondrogenic lineage. Sox9 - an early 21 
marker for chondrogenesis (Lefebvre, & de Crombrugghe 1998), is also a direct activator 22 
of the chondrocyte specific ECM gene collagen type II (Lefebvre et al 1997) along with 23 
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aggrecan - a major structural component of cartilage. The mRNA expressions of these 1 
genes were upregulated in both CI and CSI induced micromass cultures. Histological 2 
staining using Safranin-O and immunohistological staining of collagen type I and II all 3 
showed that the micromass pellets had differentiated towards the chondrogenic lineage. 4 
When the mRNA expressions of the three genes were compared between CI and CSI 5 
pellet cultures, it was observed that the level of all three genes from the CSI cultures had 6 
a higher expression level than those in CI cultures. This study demonstrated that the gene 7 
expressions of chondrogenic modified micromass pellet culture using an entire cell-sheet 8 
when compared to conventional micromass pellet culture using single cells was 9 
extensively upregulated. It is hypothesized that this was due to the ECM within the cell-10 
sheet that was able to provide the appropriate biological cues, ie suitable 11 
microenvironment and ideal cell - cytokine/growth factor interactions to differentiate the 12 
BMSCs into chondrocytes. In a published study by Hickok et al (1998), it was shown that 13 
close spatial relationships of neighbouring BMSC will give rise to better cell to cell and 14 
cell to matrix interactions which facilitates chondrogenic differentiation (Hickok et al 15 
1998). It has also been reported that BMP plays an important role in initiating 16 
chondrogenic differentiation in BMSCs (Bosnakovski et al 2006,Schmitt et al 2003). It is 17 
believed that CSI pellets provided a culture system where the cells already had well 18 
established cell - cell and extensive cell - matrix interactions, and as stated previously, the 19 
BMPs that are bound to the ECM of the cell-sheet would be able to provide the ideal cues 20 
to differentiate the BMSCs into chondrocytes (Suzawa et al 1999). 21 
There has been a study by Akahane et al, 2008 that reports BMSC cell-sheets at 22 
confluence to tend towards the osteogenic lineage. The report states that alkaline 23 
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phosphatase activity, alkaline phosphatase staining and osteocalcin contents indicate the 1 
BMSC cell-sheet tendency towards the osteogenic lineage. However, the reported method 2 
of cell-sheet fabrication had dexamethasone and β-glycerophosphate added. These are 3 
known additives for osteogenic differentiation of BMSCs, which might have induced the 4 
upregulation of the osteogenic markers detected in the report. Thus it cannot be 5 
concluded that BMSC cell-sheets tended towards the osteogenic lineage. 6 
We have shown conclusively that 2 week old BMSC cell-sheets retain their 7 
multipotentiality. Our results also show that the BMSCs within the cell-sheet might have 8 
an enhanced differentiation capability, particularly in the case of osteogenic and 9 
chondrogenic lineages when compared to differentiated cell cultures following 10 
conventional induction protocols, but more studies will have to be done to confirm this 11 
hypothesis. Hence, it is possible to use BMSC cell-sheets for more complex tissue 12 
engineering applications that require more than one cell type.  13 
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5.3 Phase III – Fabrication and Verification of a Simulated IVD-like Assembly 1 
The inner core of the IVD is consists of a turgid tissue called the nucleus pulposus. 2 
This tissue contains high proteoglycan, and causes it to exhibit a high affinity for water 3 
due to its highly negative sulfated charge (Revell et al 2007). The nucleus pulposus is 4 
also filled with Type II collagen, in random orientation. Studies have shown previously 5 
that the NP exhibits viscoelastic properties under physiological compression (Bader, & 6 
Rochefort 2008). It is “fluidlike” and relaxes to near zero stress under transient condition, 7 
while behaving like an “elastic solid” under dynamic loading (Iatridis et al 1996). In 8 
order to fabricate the simulated IVD-like assembly, a suitable NP-like substitute had to be 9 
fabricated.  10 
The mechanical properties of the NP-like substitute have to remain constant after 11 
sterilization and dynamic compression. Dow Corning’s Slygard 184 Elastomer kit was 12 
chosen as the material for the NP-like substitute due to its viscoelastic properties and 13 
biocompatibility (Brown et al 2005). The 1st part of this study was to determine a 14 
fabrication protocol to produce NP-like substitutes that had similar mechanical properties 15 
to the actual porcine NP (Glover et al 1991), and conduct further mechanical tests on its 16 
suitability for use in a compression bioreactor. The 2nd part of this study involved 17 
fabricating the entire simulated IVD-like construct using the silicone NP-like substitute 18 
wrapped with alternating layers of silk scaffolds and BMSC cell-sheets to simulate the 19 
AF, to determine the feasibility of the entire assembly to regenerate the AF. 20 
In order to determine the axial compression needed to produce a 0.05 MPa 21 
bulging pressure (Glover et al 1991), the silicone NP-like substitute was compressed in 22 
the axial direction from 15% to 30% and the bulging pressure calculated using the 23 
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formula stated in Appendix A6. It was determined that a 25% axial compression of the 1 
NP-like substitute resulted in a radial bulging pressure of 0.0505 ± 0.0023 MPa.  2 
The next characterization step was to determine if the mechanical properties of 3 
NP-like substitute would change after undergoing ethylene oxide sterilization. The 4 
Young’s modulus of the NP-like substitute at 25% axial compression will be used to 5 
determine if the mechanical properties have changed. 6 batches of NP-like substitutes 6 
were fabricated using the same protocol and sterilized using ethylene oxide. From the 7 
data of the Young’s modulus, we concluded that ethylene oxide sterilization did not 8 
affect the mechanical properties of the silicone NP-like substitute. However, it is 9 
observed that the Young’s modulus was significantly different within batches even 10 
though the fabrication process was consistent (Fig 4.3.1b). 11 
The next characterization experiment was to determine if the mechanical 12 
properties of the silicone NP-like substitute would change after cyclic loading. The 13 
experiment, done on Batch B and D was conducted over 3 consecutive days, was done 14 
for 15mins each day with a 25% axial compression at a frequency of 0.25Hz. The 15 
Young’s modulus of the NP-like substitute at 25% axial compression was calculated 16 
before and after each day of cyclic compression. The results show that the Young’s 17 
modulus of the NP-like substitute did not significantly different after each day and after 18 
the 3 consecutive days of cyclic loading (Fig 4.3.1c). 19 
From the experiments conducted thus far, the NP-like substitutes have been 20 
shown to have desirable material properties to function within the simulated IVD-like 21 
assembly. However, the inability to have a consistent Young’s modulus between batches 22 
presented a problem in standardizing the bulging pressure. It was then decided that 23 
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keeping the hoop strain constant would be more attainable. The final experiment was 1 
performed to obtain the axial compression of each batch that was needed to give a 2 
14.7±0.4% hoop strain (derived from a 25% axial compression of Batch A). The results 3 
of the experiment (Fig 4.3.1d) showed that Batches B and D required a 23% axial 4 
compression to attain a 14.7±0.5% and 14.6±0.4% hoop strain respectively, which 5 
batches C, E and F required a 24% axial compression to attain a 15.1±0.3%, 15.0±0.6% 6 
and 15.0±0.8% hoop strain respectively (details of results in Appendix A9). 7 
It can be concluded that the Dow Corning Sylgard 184 Elastomer Kit was able to 8 
fabricate the NP-like substitutes with suitable mechanical properties in a 20:1 9 
(elastomer:harderner) ratio. The mechanical properties of the NP-like substitutes 10 
remained constant after ethylene oxide sterilization and 3 consecutive days of cyclic 11 
loading and an axial compression of between 23% to 25% (depending on Batch) was 12 
required standardize the hoop strain of each batch at 14.7%. 13 
After successfully fabricating the NP-like substitute, the simulated IVD-like 14 
assembly was fabricated using 2 week old BMSC cell-sheets and combined silk scaffolds 15 
as the simulated AF (Fig 3.3.4). The simulated IVD-like assembly was cultured for 4 16 
weeks in static conditions using only LG-DMEM supplemented with 15% FBS, 1% 17 
penicillin/streptomycin, 1% L-Glutamine and 50µg/ml L-Asc. The feasibility of the 18 
simulated IVD-like assembly to aid IVD regeneration was verified by a series of assays. 19 
The results of the Alamar Blue assay confirmed that cells within the BMSC cell-20 
sheet of the simulated IVD-like assembly remained viable throughout the 4 week static 21 
culture period (Fig 4.3.2a). Histological staining of sections of the simulated IVD-like 22 
assembly showed the localization of the cells and ECM in between layers of the silk 23 
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scaffold. The staining showed that the BMSC cell-sheets had adhered onto the silk 1 
scaffolds. However, there was no evidence that the cells from the cell-sheet migrated into 2 
the pores of the silk scaffold. The positive Alcian Blue and negative Safranin-O staining 3 
(Fig 4.3.2b) of the sections showed that the GAG present within the ECM was poorly 4 
sulphated mucopolysaccharide (Chan et al 2001). Immunohistological staining of 5 
collagen type I and collagen type II the sections show evidence of both collagen types 6 
within the ECM (Fig 4.3.2c). Further analysis of the collagen content within the ECM of 7 
the simulated IVD-like assembly shows evidence of a decrease in collagen type I 8 
detected within the ECM. Before transplantation into the simulated IVD-like assembly, 9 
the ECM was made up of mainly of collagen type I. However, after 4 weeks of static 10 
culture in the simulated IVD-like assembly, the amount of collagen type I detected within 11 
the ECM decreased as shown in the SDS-PAGE gel (Fig 4.3.2d). This might suggest that 12 
the ECM composition is going through extensive remodeling as shown by the 13 
immunohistochemical staining results. The positive staining for collagen type II suggest 14 
that the ECM is tending towards that of the inner AF where collagen type II makes up a 15 
larger proportion of the ECM (Beard et al 1981). Since there have been no distinct 16 
markers that can be used to differentiate IVD cells from cartilage cells, we also felt that 17 
this hypothesis is also in agreement with previous studies that have shown that silk 18 
scaffolds are suitable for cartilage tissue engineering (Wang et al 2005,Hofmann et al 19 
2006).  20 
The remodeling of the ECM might be due to the change in the substrate that the 21 
cells attach on. The cell-sheets were initially attached onto poly-NIPAAm coated surfaces 22 
and we hypothesize that the change in the substrate when transplanted onto the silk 23 
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scaffolds caused a biochemical alteration of the cells in the cell-sheet which in turn 1 
caused the remodeling of the ECM. We also hypothesize that the remodeling of the ECM 2 
is partially due to the radial compressive force experienced by the cell-sheet due to the 3 
wrapping of the silk scaffolds around the silicone NP. This hypothesis is somewhat in 4 
agreement with previous studies that have shown that cyclic compression can induce 5 
BMSCs to undergo chondrogenesis (Huang et al 2004) and an increase in compressive 6 
load in AF cells causes matrix remodeling expression (Wenger et al 2005). However, 7 
more experiments have to be done to determine the molecular mechanisms that caused 8 
this extensive change in the ECM composition over a period of 4 weeks. 9 
Recently, there has been a report that attempted to regenerate the AF using 10 
BMSCs seeded onto aligned, electrospun poly(ε-caprolactone) (PCL) (Nerurkar et al 11 
2009). The group had concluded that structural hierarchy of the AF was attained by the 12 
aligned nanofibres, and after seeding the scaffolds with BMSCs and culturing then in 13 
chondrogenic differentiation medium for 10 weeks, the construct was suitable for AF 14 
regeneration. However, one contradictory point in the study was that it seemed that with 15 
the use of aligned scaffolds, the aim was to regenerate the outer AF, but the medium of 16 
choice had been used extensively for chondrogenic differentiation. This would cause the 17 
BMSCs to differentiate towards the chondrogenic lineage and deposit extracellular matrix 18 
similar to the inner AF and NP. The group had also reported an increase in collagen 19 
deposition over the 10 week culture duration. However, the exact composition of 20 
collagen type was not determined in this study. It has been extensively reported that the 21 
outer AF is made up of mainly collagen type I and to a much lesser extent, collagen type 22 
II and the amount of collagen type I fibres decrease and collagen type II fibres increase 23 
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gradually near the NP (Bruehlmann et al 2002), thus it cannot be concluded if the group 1 
was attempting to regenerate the inner or outer AF. This group also reported the lack of 2 
BMSC migration into the electrospun scaffolds due to the small pore size and dense 3 
nanofibre packing of the scaffolds. Therefore, although the study done by this group to 4 
mimic the native structural hierarchy of the outer AF seems promising, we were not able 5 
to determine if their goal was to regenerate the inner or outer AF. 6 
In this phase of experiments, we have shown that the cell-sheets transplanted into 7 
the simulated IVD-like assembly remains viable and go through extensive extracellular 8 
matrix remodeling throughout the 4 week static culture period. There was a significant 9 
decrease in collagen type I composition within the ECM, coupled by the detection of 10 
collagen type II by immunohistochemical analysis, it seems that the composition of the 11 
ECM found within the 4 week static cultured simulated IVD-like assembly might be that 12 
found between the inner and outer AF. However, the exact cause and mechanism for the 13 
ECM remodeling has yet to be determined.  14 
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5.4 Phase IV – Bioreactor Studies of Simulated IVD-like Assembly  1 
 There have been a number of reports using mechanical stimulus to try to achieve 2 
increased IVD cell proliferation, increased mRNA expression and matrix deposition of 3 
the related proteins (Iwashina et al 2006,Miyamoto et al 2005,Wenger et al 2005). It is 4 
hypothesized that stress fibres within the cells detect the mechanical stimulus and adapt 5 
accordingly. When the NP within the IVD is compressed, the AF cells undergo a 6 
concentric tensile and radial compression stress due to the radial bulging of the NP. 7 
Recent work involving mechanical stimulus to regenerate the AF uses hydrostatic (Reza, 8 
& Nicoll 2008) and hydrodynamic (Gokorsch et al 2004) pressure on the AF cells. 9 
Dynamic hydrostatic pressure was shown to enhance deposition and organization of the 10 
ECM from the cells derived from the outer AF, however, the cells from the inner AF was 11 
not as responsive (Reza, & Nicoll 2008). Hydrodynamic pressure on AF cells seeded 12 
within agarose also induced the cells to produce more ECM, mainly sGAG (Gokorsch et 13 
al 2004). A more recent report showed that the application of a 10% equibiaxial cyclic 14 
tensile strain was able to increase collagen and sGAG synthesis of previously compressed 15 
AF cells (Hee et al 2010). However, these methods of application of mechanical stimulus 16 
do not accurately represent the physiological conditions experienced when forces are 17 
transmitted throughout the IVD. Moreover, these studies all involve the use of AF cells 18 
where it would not be feasible to obtain healthy autologous AF cells as it would involve 19 
taking a biopsy of a healthy AF from which to extract the cells. This would mean that a 20 
healthy AF would have to be punctured and thereby damaging structure and mechanical 21 
function.  22 
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With these limitations in mind, a bioreactor was designed to be able to apply and 1 
control cyclic axial compression, applied on a silicone NP-substitute. The silicone NP-2 
substitute would translate the axial force into a hoop strain in the radial direction to 3 
stimulate an AF-like assembly made up of BMSC cell-sheets seeded onto silk scaffolds. 4 
The unique facets of this study design was to use a rehabilitative stimulation regime and a 5 
silicone NP substitute to mimic the physiological transmission of forces to the BMSC 6 
cell-sheets and silk scaffolds that make up the simulated AF.  7 
 The results from the Alamar Blue assay suggest that the cells were able to survive 8 
the dynamic culture conditions. However, cellular activity of the BMSCs within cell-9 
sheet of the mechanically stimulated simulated IVD-like assembly initially increased till 10 
Week 2 and then decreased after that. The viability of the mechanically stimulated cells 11 
ended up being significantly reduced when compared to the static control (Fig 5.4.1a). 12 
This might be due to the loss of cell viability of the BMSC as they are induced to 13 
differentiate (Yamashita et al 2009,Nuttelman et al 2004) or driven to cell dearh by the 14 
compressive forces experienced (Kroeber et al 2002). 15 
 There have been no reports on markers and genes specific to the IVD. A previous 16 
study has shown that AF cells express cartilage-specific matrix proteins albeit with 17 
quantitative differences when compared to articular chondrocytes (Poiraudeau et al 1999). 18 
Therefore, most of the studies that have been conducted, use chondrogenic genes (Chang 19 
et al 2007,Korecki et al 2009,Kuh et al 2009). The ECM of the AF provides strength and 20 
distributes load over large parts of the AF. The assembly of the ECM is catalyzed by both 21 
biglycan and decorin. A diminished function of these molecules will lead to a loss of 22 
mechanical properties of the collagen network and results in the inability of the AF to 23 
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resist the hoop stresses delivered by the NP (Bron et al 2009). At 2 weeks of dynamic 1 
culture in the bioreactor, only collagen type II mRNA was significantly upregulated over 2 
the static control group. However, after 4 weeks of dynamic culture, the mRNA 3 
expression of all these genes except biglycan became significantly upregulated when 4 
compared to the static control group (Fig 4.4.1e). Histological staining using Alcian Blue 5 
and Safranin-O showed that the GAG within the ECM of the simulated IVD-like 6 
assembly has become more sulphated due to the mechanical stimulation of the entire 7 
assembly (Fig 4.4.1c). These histological results are in agreement to a study done by 8 
(Leung et al 2009) on IVD growth and degeneration. Immunohistological staining of 9 
collagen type I and II also confirm the presence of both types of collagen within the ECM 10 
of the simulated IVD-like assemblies cultured in the bioreactor (Fig 4.4.1d). 11 
 Pepsin digestion was done to extract and quantify the collagen found within the 12 
ECM of the samples. SDS-PAGE analysis was done to detect collagen type I and an 13 
immunoblot was done to detect collagen type II. Collagen type II could not be accurately 14 
quantified by SDS-PAGE as the collagen type II α1 chain is expected to co-migrate with 15 
the collagen type V α2 chain. After 2 weeks of dynamic culture, the amount of collagen 16 
type I detected in the SDS-PAGE gel and collagen type II detected in the western 17 
immunoblot was lesser than the static control even though the collagen type II gene 18 
expression was already significantly upregulated. However, after 4 weeks of dynamic 19 
culture, the amount of collagen type I found within the ECM was significantly decreased 20 
while a strong signal of collagen type II was detected in the immunoblot. This showed 21 
that there was a large increase in collagen type II deposition had occurred during the 3rd 22 
and 4th week of dynamic culture (Fig 4.4.1b). The collagen composition profile is similar 23 
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to that of the inner AF where collagen type II makes up a larger proportion of the ECM 1 
over collagen type I (Beard et al 1981). When in collagen composition profile was 2 
compared against the static control, it was found that the ECM continued to go through 3 
extensive matrix remodeling to a point where there was barely any collagen type I. The 4 
presence of collagen type V bands might play an important role in the remodeling of the 5 
ECM, however, the specific functional role of collagen type V in the AF has not been 6 
reported. 7 
Most studies are done using AF cells with various methods of mechanical 8 
stimulation with a wide range of magnitudes, frequencies and durations (Hee et al 9 
2010,Reza, & Nicoll 2008,Gokorsch et al 2004,Gokorsch et al 2005,Iwashina et al 2006), 10 
thus it would not be feasible to compare the reported results obtained with the one we 11 
have presented. Very recently, there has been a study done using BMSCs seeded onto 12 
aligned nanofibres to regenerate the AF (Nerurkar et al 2009), and the same group 13 
subsequently used dynamic culture conditions to further enhance cell infiltration into the 14 
scaffolds (Nerurkar et al 2010). The group reported that culturing the constructs in 15 
chondrogenic differentiation medium on an orbital shaker for 6 weeks followed by 16 
another 6 weeks of static culture also improved the sGAG and collagen deposition when 17 
compared to 12 weeks of dynamic and 12 weeks of static culture. However, like in their 18 
previous report, there was no mention of the composition of the collagen type within the 19 
ECM nor was there any gene expression analysis done to determine if the seeded BMSCs 20 
had begun to differentiate towards a particular mesenchyme lineage.  21 
None of the previous studies have attempted to regenerate the AF by stimulating 22 
the cells with forces as it would experience within the native IVD. Our method of using a 23 
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cylindrical silicone NP to translate an external axial force to the AF (radial compressive 1 
and circumferential tensile) to induce the BMSC cell-sheets to adopt an AF-like 2 
morphology and biochemistry is unique. However, our data is in agreement with previous 3 
reports, that some form of compression or increase in pressure was able stimulate the 4 
cells to produce more ECM to improve the regeneration of the AF.  5 
 126 
5.5 Summary 1 
In summary, although this is just a preliminary study using BMSC cell-sheets as a 2 
cell source, fabricated into a simulated IVD-like assembly and mechanically stimulated 3 
by a bioreactor in attempt to regenerate the inner AF. We have managed to show 4 
conclusively that the cells within the BMSC cell-sheet were able to survive the 5 
rehabilitative regime in the bioreactor. Not only did the cells survive, the gene expression 6 
and protein deposition results obtained indicate that the ECM found within the simulated 7 
IVD-like assembly after dynamic culture was capable of regenerating a tissue structure 8 
similar to that found in the native inner AF (Bron et al 2009,Reza, & Nicoll 2008,Wan et 9 













6. CONCLUSION 1 
 The findings from Phase I established the method of growing the BMSC cell-2 
sheet. The cell-sheet growth profile was also successfully characterized. During the 3 
course of characterizing the cell-sheet growth profile, a novel method to enhance the 4 
accuracy of collagen quantification was also discovered. 5 
 In Phase II, the multipotency of the BMSCs of 2 week old BMSC cell-sheets was 6 
examined. The 2 week old cell-sheets were differentiated into the 3 main mesenchymal 7 
lineages; adipogenic, chondrogenic and osteogenic lineage. It was found that despite 2 8 
weeks of hyperconfluent culture to form the cell-sheet, the BMSCs still retained the 9 
multipotency to these 3 lineages, contrary to previous findings that BMSC self 10 
differentiate in hyperconfluent conditions. 11 
 In Phase III, a fabrication protocol was established to fabricate a silicone NP-like 12 
substitute. The fabricated silicone NP-like substitute was found to retain its mechanical 13 
properties after ethylene oxide sterilization and consecutive days of cyclic loading. A 14 
simulated IVD-like assembly was fabricated using the pre-fabricated silicone as the NP 15 
substitute and alternating layers of BMSC cell-sheet and silk scaffold as the AF. It was 16 
shown that the simulated IVD-like assembly remained viable after 4 weeks of static 17 
culture and the composition of the ECM was made up of both collagen types I and II. The 18 
ECM formed is similar to what is expected between the inner and outer AF.   19 
 In Phase IV, a bioreactor was fabricated to compress the simulated IVD-like 20 
assembly as in physiological conditions. The results illustrated that a rehabilitative 21 
mechanical stimulation from the bioreactor was able to induce the cells within the cell-22 
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sheet to adopt a discogenic gene expression and remodel the ECM in a profile similar to 1 
that of the inner AF. 2 
 Collectively, this doctoral work has satisfied all the stated objectives in each 3 
phase, and to a certain extent, the hypothesis. To successfully regenerate the AF, the 4 
appropriate cell source, scaffold and mechanical stimulation would have to come together. 5 
A mechanically stimulated simulated IVD-like assembly was successfully fabricated to 6 













7. RECOMMENDATIONS 1 
 The main aim of this study was to determine if a novel method of fabricating a 2 
simulated IVD-like assembly would be feasible in AF regeneration, and if the fabricated 3 
bioreactor that would simulate the in vivo physiological loading mechanism could 4 
enhance the AF regeneration. 5 
 During the 4 week dynamic culture period of the simulated IVD-like assembly in 6 
the bioreactor, there was no means possible to monitor the growth progress without 7 
having to sacrifice the assembly. It is recommended that a load cell be incorporated into 8 
the design of the bioreactor to monitor the forces experienced by the assembly real-time. 9 
It is hypothesized that if a more robust matrix is deposited by the cells, the load cell 10 
reading would be able to detect the change. Another recommendation would be to use 11 
chondrogenic induction medium supplemented with TGFβ3 in the bioreactor. It is 12 
hypothesized that the induction medium would enhance the efficiency of differentiation 13 
of BMSCs into the inner AF cells over mechanical stimulation alone. 14 
 Furthermore, the simulated IVD-like assembly was done using only 3 layers of 15 
scaffolds and 2 “lamellae” of BMSC cell-sheets. The mechanical stimulation caused a 16 
radial bulging throughout the entire assembly. It is recommended that more “lamellae” of 17 
BMSC cell-sheets can be added onto the assembly to try to regenerate the outer AF. 18 
It was also observed that throughout the static and dynamic culture of the 19 
simulated IVD-like assembly, the cells within the cell-sheets did not migrate into the 20 
pores of the silk scaffolds. This would pose a problem in forming a robust tissue structure 21 
when the silk scaffolds start to degenerate. It is recommended that for the inner AF, the 22 
method of electrospraying BMSCs while electrospinning nanofibres can be used to form 23 
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scaffolds that are well populated with cells throughout the entire thickness. This would 1 
alleviate the problem of the cells from the cell-sheet not migrating into the pores of the 2 
scaffold. As for the outer AF, a novel method of electrospraying BMSCs while 3 
electrospinning aligned nanofibres can be used to mimic the aligned fibres found in the 4 
native outer AF. Alternating layers and directions of these electrosprayed-electrospun 5 
aligned scaffolds can be used to mimic the native lamellae of the IVD. On top of these, 6 
the inner AF and the outer AF can be cultured in media containing TGFβ3 and bFGF 7 
respectively to differentiate the BMSCs towards the chondrogenic and fibroblastic 8 
lineage. 9 
From the analysis of the SDS-PAGE results of the ECM in the simulated IVD-10 
like assembly, collagen type V was deposited in large amounts. However the function of 11 
collagen type V in the AF has not been determined. It would be beneficial to determine if 12 
collagen type V was responsible for the down regulation of collagen type I deposition or 13 
if it is a precursor to collagen type II deposition. It might possibly be a marker for inner 14 
AF cells. 15 
Finally, it is widely reported that articular cartilage cells and IVD cells are 16 
different in morphology and phenotype. However, there are no markers that have been 17 
discovered to positively differentiate IVD cells from those from the articular cartilage, 18 
thus all studies have been using chondrogenic markers to prove that a discogenic 19 
phenotype was obtained. Without a series of markers unique in expression from other cell 20 
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9. APPENDICES 1 
A1. Formula for Calculation of Alamar Blue Reduction 2 
 3 
( )( ) ( )( )











λ1=570nm, λ2=600nm 5 
(εredλ1) = 155677 (Molar extinction coefficient of reduced Alamar BlueTM at 570nm) 6 
(εredλ2) = 14652 (Molar extinction coefficient of reduced Alamar BlueTM at 600nm) 7 
(εoxλ1) = 80586 (Molar extinction coefficient of oxidized Alamar BlueTM at 570nm) 8 
(εoxλ2) = 117216 (Molar extinction coefficient of oxidized Alamar BlueTM at 600nm) 9 
(Aλ1) = Absorbance of test wells at 570nm 10 
(Aλ2) = Absorbance of test wells at 600nm 11 
(A’λ1) = Absorbance of negative control wells which contain medium plus Alamar 12 
BlueTM but to which no cells have been added at 570nm 13 
(A’λ2) = Absorbance of negative control wells which contain medium plus Alamar 14 
BlueTM but to which no cells have been added at 600nm 15 
 162 
A2. 3%/5% SDS Gel making Protocol 1 
5% Separation Gel (1mm thickness) for Collagen 2 
 1 Gel (µl) 2 Gel (µl) 
30% Acrylamid/Bis (37.5 : 1) 830 1660  
1.875M Tris (pH 8.8) 1000 2000 
10% SDS 50 100  
ddH2O 3070 6140 
APS (100mg/ml) 42 84 
TEMED 5 10 
Total 5ml 10ml 
 3 
3% Stacking Gel 4 
 1 Gel (µl) 2 Gel (µl) 
30% Acrylamid/Bis (37.5 : 1) 200µl 400µl 
1.25M Tris (pH 8.8) 200µl 400µl 
10% SDS 33µl 66µl 
ddH2O 1550µl 3100µl 
APS (100mg/ml) 17µl 33µl 
TEMED 3µl 6µl 
Total 2ml 4ml 
 5 
1. Clean glass plates with 70% Ethanol and wipe dry. 6 
a. Assemble the gel making apparatus  7 
2. Add the 5% resolving gel ingredients into the space between the 2 glass plates to  8 
3. Overlay with 10% Ethanol to cut-off O2 contact. 9 
4. Leave for 30mins. 10 
5. Alcohol and Resolving gel interface will disappear and reappear after 30mins, 11 
indicating that polymerization is complete. 12 
6. Pour off Ethanol, wash with ddH2O and use filter paper to absorb remaining 13 
traces of water. 14 
7. Add APS and TEMED to 3% Stacking gel and pour it on top of the polymerized 15 
resolving gel and immediately insert the comb of choice. 16 
a. Leave for 10mins.  17 
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8. Remove comb gently 1 
9. Wash with running buffer.2 
 164 
A3. Silver Staining Protocol 1 
Volume Step Reagent 
1 mini gel 2 mini gels 1 big gel 2 big gels 
Fast Protocol Basic Protocol 
Fix 
Ethanol (40%) 
Acetic Acid (10%) 
Water 
50 100 150 300 
1hr/overnight 1hr/overnight 























1st Wash Ethanol (30%) Water 50 100 150 300 
N.A. 10mins 
1st Wash Water 50 100 150 300 Microwave 30sec Agitate 2mins 
N.A. 
2nd Wash Water 50 100 150 300 Microwave 30sec Agitate 2mins 
10mins 





























5-8mins or when dark 
bands start to show 
5-8mins or when dark 
bands start to show 
Stop Stopper 5 10 15 30 
Add directly to 
developing solution, 
pour on gel, 10mins 
Add directly to 
developing solution, 
pour on gel, 10mins 
Wash Water 50 100 150 300 10mins 10mins 
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A4. 5%/7% SDS Gel making Protocol 1 
7% Separation Gel 2 
 3 




1.875M Tris (pH 8.8) 1.25ml 2.5ml 
10% SDS 50µl 100µl 
ddH20 2.32ml 4.64ml 
APS 50µl 100µl 
TEMED 2µl 4µl 
Total 5ml 10ml 
 4 
 5 
5% Stacking Gel 6 
 7 




1.25M Tris (pH 6.8) 0.315ml 0.63ml 
10% SDS 25µl 50µl 
ddH2O 1.7ml 3.4ml 
TEMED 2.5µl 5µl 
APS (100mg/ml) 25µl 50µl 
Total 2ml 4ml 
 8 
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A5. Solidworks Drawings of Bioreactor Parts 1 




Motor Support Plate 
 
























CAD drawing of Motor Support Plate 1 
 2 
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CAD Drawing of Motor Support Pin 1 
 2 
 169 
CAD Drawing of Motor-Platen Coupling 1 
 2 
 170 
CAD Drawing of Movable Platen 1 
 2 
 171 
CAD Drawing of Rotation Restriction Plate 1 
2 
 172 
CAD Drawing of Chamber Cover 1 
 2 
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CAD Drawing of Acrylic Chamber Case 1 
 2 
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CAD Drawing of Chamber Platform 1 
2 
 175 
CAD Drawing of Chamber Base 1 
 2 
  3 
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A6. Detailed Calculations to Determine Swelling Pressure of Silicone NP 1 
 2 
y = -1969411.29x3 + 2329465.15x2 + 225559.55x - 231.86 3 
dy/dx = -5908233.87x2 + 4658930.3x + 225559.55 4 
Young’s modulus at 25% compression =   5 
εθ = [σθ – ν (σr + σa)] 6 
Since σr = 0 7 
εθ = (σθ – ν σa) 8 
σθ = E εθ + ν σa 9 










Calculations of Hoop Stress at different Axial Compressions 1 
ε 




Modulus  Poisson's Ratio Hoop Stress 
    (Mpa)    (Mpa)    (Mpa) 
16% 0.069602273 -0.11988868 -0.1600403 1.077 0.434904663 0.022821502 
18% 0.088068182 -0.141620492 -0.1800577 1.13 0.48911089 0.030248921 
20% 0.103693182 -0.164293971 -0.2000915 1.174 0.518228819 0.036593925 
22% 0.119318182 -0.187558003 -0.2200102 1.211 0.542330227 0.042775944 
24% 0.132102273 -0.211880857 -0.2400276 1.239 0.550362845 0.047063365 
26% 0.147727273 -0.237096041 -0.2600779 1.259 0.568011633 0.051315327 
28% 0.164772727 -0.263304439 -0.2800952 1.272 0.588274013 0.05469575 
30% 0.177556818 -0.290302777 -0.3000468 1.276 0.591763745 0.054771841 
 2 
25% 0.140625 -0.224763793 -0.2500317 1.248 0.562428684 0.049086396 
 3 













A1 0.15 -0.2500032 -
0.24906909 
1.307 0.59999232 0.04605 
A2 0.140625 -0.22476379 -0.2500317 1.248 0.562428684 0.049086396 
A3 0.14640884 -0.27278432 -0.2500356 1.346 0.536720132 0.050657459 
A4 0.15 -0.27246495 -0.2500687 1.363 0.550529515 0.05445 
A5 0.15 -0.25926296 -0.2500304 1.35 0.57856316 0.0525 
     Average 0.050548771 
 






A7. Details of Young’s Modulus for Batches A to F 1 
Young’s Modulus of Pre-Sterilized and Sterilized Silicone Discs 
Batch A Batch B Batch C Batch D Batch E Batch F 
 
Before After Before After Before After Before After Before After Before After 
Sample 1 1.307 1.295 1.048 1.052 1.219 1.079 1.135 1.182 1.294 1.342 1.265 1.247 
Sample 2 1.248 1.284 1.159 1.041 1.026 1.003 1.143 1.128 1.151 1.301 1.245 1.264 
Sample 3 1.346 1.334 1.004 1.031 0.948 1.031 1.086 1.038 1.263 1.252 1.287 1.248 
Sample 4 1.363 1.319 0.965 1.096 1.143 1.05 1.141 1.125 1.210 1.244 1.212 1.199 
Sample 5 1.35 1.347 1.014 1.026 0.997 1.061 1.111 1.200 1.250 1.259 1.274 1.228 
Average 1.3228 1.316 1.038 1.049 1.067 1.045 1.123 1.135 1.233 1.280 1.257 1.237 
Standard 
Deviation 
0.0467 0.0235 0.0738 0.0281 0.111 0.0292 
 
0.0243 0.0634 0.0552 0.0416 0.0293 0.0248 
P value p=0.6605>0.05 p=0.5938>0.05 p=0.4641>0.05 p=0.4993>0.05 p=0.1669>0.05 p=0.0533>0.05 
 2 
 179 
A8. Details of Cyclic Loading Testing 1 
Young’s Modulus of Batch B Young’s Modulus of Batch D 
Day 1 Day 2 Day 3 Day 1 Day 2 Day 3 
 
Before After Before After Before After Before After Before After Before After 
Sample 1 1.011 0.938 1.065 1.016 1.144 1.097 1.224 1.262 1.299 1.166 1.254 1.250 
Sample 2 0.969 1.055 1.012 1.122 1.054 1.059 1.143 1.113 1.174 1.147 1.168 1.142 
Sample 3 0.977 0.945 0.937 0.968 0.982 1.020 1.065 1.155 1.100 1.144 1.141 1.119 
Sample 4 0.979 0.966 1.089 1.073 0.993 1.046 1.152 1.243 1.184 1.100 1.178 1.171 
Sample 5 1.100 1.066 0.987 1.021 1.074 1.042 1.215 1.198 1.191 1.198 1.152 1.222 
Average 1.007 0.994 1.018 1.040 1.050 1.053 1.160 1.194 1.190 1.151 1.179 1.181 
Standard 
Deviation 0.0543 0.0616 0.0608 0.589 0.0656 0.0286 0.0643 0.0614 0.0713 0.0357 0.0442 0.0545 
P value p=0.366>0.05 p=0.293>0.05 p=0.461>0.05 p=0.412>0.05 p=0.323>0.05 p=0.938>0.05 
 2 
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A9. Details of Hoop Strain Standardization 1 
 2 
Batch A Batch B Batch C Batch D Batch E Batch F  
25% 20% 23% 20% 23% 24% 25% 23% 25% 24% 25% 24% 
Sample 1 0.15 0.1056 0.1441 0.1201 0.1268 0.1538 0.1607 0.1527 0.1607 0.1538 0.1637 0.1386 
Sample 2 0.1406 0.1071 0.1555 0.0887 0.1321 0.1483 0.1571 0.1442 0.1571 0.1404 0.1571 0.1553 
Sample 3 0.1464 0.121 0.1489 0.0922 0.1238 0.1485 0.1667 0.1476 0.1555 0.1576 0.1549 0.1443 
Sample 4 0.15 0.1075 0.1471 0.1263 0.0848 0.1522 0.1809 0.1408 0.1577 0.1505 0.1495 0.1579 
Sample 5 0.15 0.1103 0.1404 0.1025 0.0583 0.1525 0.1625 0.1462 0.1702 0.1456 0.1596 0.1535 
Average 0.1474 0.1103 0.1472 0.106 0.1275 0.1511 0.1656 0.1463 0.1603 0.1496 0.157 0.1499 
Standard 
Deviation 0.0041 0.0062 0.0056 0.0167 0.0042 0.0025 0.0092 0.0044 0.0059 0.0068 0.0053 0.0081 
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